+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 42292

Chapter 42292 contains a list of PDF Full Texts available from EurekaMag.





Fövényi, J.; Garam, T.; Tótpál, K.; Thaisz, E.; Bakács, T., 1983:
Antibody-mediated cytotoxic activity off circulating lymphocytes directed against human red blood cells in type I and type II diabetes

Sissons, J.G.; Oldstone, M.B., 1980:
Antibody-mediated destruction of virus-infected cells

Genco, R.J.; Mashimo, P.A.; Krygier, G.; Ellison, S.A., 1974:
Antibody-mediated effects on the periodontium

Hotta, H.; Wiharta, A.S.; Hotta, S., 1984:
Antibody-mediated enhancement of dengue virus infection in mouse macrophage cell lines, Mk1 and Mm1

Wei, A.P.; Blumenthal, D.K.; Herron, J.N., 1994:
Antibody-mediated fluorescence enhancement based on shifting the intramolecular dimer<-->monomer equilibrium of fluorescent dyes

Wainberg, M.A.; Howe, C., 1972:
Antibody-mediated fusion of FL amnion cells infected with parainfluenza virus type 2

Chakraborty, A.K.; Chakravarty, A.K., 1984:
Antibody-mediated immune response in the bat, Pteropus giganteus

Pollack, W.; Gorman, J.G.; Hager, H.J.; Freda, V.J.; Tripodi, D., 1968:
Antibody-mediated immune suppression to the Rh factor: animal models suggesting mechanism of action

Ammann, A.J.; Sutliff, W.; Millinchick, E., 1974:
Antibody-mediated immunodeficiency in short-limbed dwarfism

Morton, J.I.; Siegel, B.V., 1972:
Antibody-mediated immunodepression in New Zealand black mice

Emmerling, P.; Finger, H., 1973:
Antibody-mediated immunosuppression after minimal antigenic stimulation

Zighelboim, J.; Bonavida, B.; Fahey, J.L., 1974:
Antibody-mediated in vivo suppression of EL4 leukemia in a syngeneic host

Brandriss, M.W.; Schlesinger, J.J., 1984:
Antibody-mediated infection of P388D1 cells with 17D yellow fever virus: effects of chloroquine and cytochalasin B

Schlesinger, J.J.; Brandriss, M.W., 1981:
Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus

Olson, G.A.; Guggenheim, B.; Small, P.A., 1974:
Antibody-mediated inhibition of dextran-sucrose-induced agglutination of Streptococcus mutans

Woodland, R.T., 1984:
Antibody-mediated inhibition of effector B and T cell function

Chang, K.P., 1981:
Antibody-mediated inhibition of phagocytosis in Leishmania donovani-human phagocyte interactions in vitro

Röllinghoff, M.; Warner, N.L., 1973:
Antibody-mediated inhibition of primary antibody formation in vivo and vitro in NZB mice

Rosenthal, A.S.; Davie, J.M.; Rosenstreich, D.L.; Cehrs, K.U., 1973:
Antibody-mediated internalization of B lymphocyte surface membrane immunoglobulin

Drachman, D.B.; Adams, R.N.; Josifek, L.F.; Pestronk, A.; Stanley, E.F., 1981:
Antibody-mediated mechanisms of ACh receptor loss in myasthenia gravis: clinical relevance

Rammohan, K.W.; McFarland, H.F.; Bellini, W.J.; Gheuens, J.; McFarlin, D.E., 1983:
Antibody-mediated modification of encephalitis induced by hamster neurotropic measles virus

Rotman, B.; Ellis, J.H., 1972:
Antibody-mediated modification of the binding properties of a protein related to galactose transport

Dickson, C.; Elkington, J.; Hales, A.; Weiss, R., 1980:
Antibody-mediated neutralization of virus is abrogated by mycoplasma

Schanfield, M.S., 1981:
Antibody-mediated perinatal diseases

Netuschil, L.; Kurth, R., 1980:
Antibody-mediated polysome precipitation as a method for the size determination of viral mRNA species: viral envelope glycoprotein mRNA of avian sarcoma viruses

Katayama, I.; Hashimoto, K.; Nishioka, K., 1985:
Antibody-mediated rosette formation of epidermal cells with leukocytes in pemphigus vulgaris

Shin, H.S.; Kaliss, N.; Borenstein, D., 1972:
Antibody-mediated suppression of grafted lymphoma cells. I. Participation of a host factor(s) other than complement

Shin, H.S.; Kaliss, N.; Borenstein, D.; Gately, M.K., 1972 :
Antibody-mediated suppression of grafted lymphoma cells. II. Participation of macrophages

Shin, H.S.; Hayden, M.L.; Gately, C.L., 1974:
Antibody-mediated suppression of lymphoma: participation of platelets, lymphocytes, and nonphagocytic macrophages

Feldmann, M.; Diener, E., 1971:
Antibody-mediated suppression of the immune response in vitro. 3. Low zone tolerance in vitro

Feldmann, M.; Diener, E., 1970:
Antibody-mediated suppression of the immune response in vitro. I. Evidence for a central effect

Diener, E.; Feldmann, M., 1970:
Antibody-mediated suppression of the immune response in vitro. II. A new approach to the phenomenon of immunological tolerance

Safford, J.W.; Tokuda, S., 1971:
Antibody-mediated suppression of the immune response: effect on the development of immunologic memory

Gelfand, E.W.; Resch, K.; Prester, M., 1972:
Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations

Resch, K.; Gelfand, E.W.; Prester, M., 1974:
Antibody-mediated target cell lysis by nonimmune cells: the use of anti-immunoglobulin to distinguish effector cell population

Poznansky, M.J.; Bhardwaj, D., 1981:
Antibody-mediated targeting of alpha-1,4-glucosidase-albumin polymers to rat hepatocytes. A model for enzyme therapy

Miller, R.G.; Milner-Brown, H.S.; Dau, P.C., 1981:
Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange

Munns, T.W.; Liszewski, M.K.; Hahn, B.H., 1984:
Antibody-nucleic acid complexes. Antigenic domains within nucleosides as defined by solid-phase immunoassay

Munns, T.W.; Liszewski, M.K.; Tellam, J.T.; Ebling, F.M.; Hahn, B.H., 1982:
Antibody-nucleic acid complexes. Identification of antigenic determinant of a murine monoclonal antibody specific for single-stranded nucleic acids

Hazleman, B.L.; Currey, H.L., 1973:
Antibody-producing capacity in rheumatoid arthritis

Karch, H.; Nixdorff, K., 1981:
Antibody-producing cell responses to an isolated outer membrane protein and to complexes of this antigen with lipopolysaccharide or with vesicles of phospholipids from Proteus mirabilis

Mellbye, O.J., 1971:
Antibody-producing cells in bone marrow and other lymphoid tissues during the primary immune response in mice

Chang, C.C.; Winter, A.J.; Norcross, N.L., 1980:
Antibody-producing cells in bovine lacteal secretions after local immunization

Hraba, T.; Madar, J.; Karakoz, I., 1984:
Antibody-producing cells in chickens tolerant to human serum albumin

Stern, M.H.; Dreizen, S.; Mackler, B.F.; Levy, B.M., 1981:
Antibody-producing cells in human periapical granulomas and cysts

Masuda, T., 1966:
Antibody-producing cells in lymphatic tissue--review on the one cell-one immunoglobulin concept

Daniels, J.C.; Weigle, W.O., 1968:
Antibody-producing cells in rabbits injected with soluble BSA. I. Hemolytic plaque assay

Daniels, J.C.; Weigle, W.O., 1968:
Antibody-producing cells in rabbits injected with soluble BSA. II. Kinetica and dose response

Fagraeus, A., 1981:
Antibody-producing cells: a survey of four decades of research development

Phillips, R.A.; Miller, R.G., 1970:
Antibody-producing cells: analysis and purification by velocity sedimentation

Holt, J.A.; Lorincz, M.A.; King, W.J., 1983:
Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma

Roth, M.G.; Compans, R.W., 1980:
Antibody-resistant spread of vesicular stomatitis virus infection in cell lines of epithelial origin

Foxwell, B.M.; Ross, W.C.; Thorpe, P.E., 1984:
Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin

Martínez-Maza, O.; Fehniger, T.E.; Ashman, R.F., 1983:
Antibody-secreting cell precursor frequencies among the sheep-erythrocyte-binding cells after immunization

Klinman, N.R., 1981:
Antibody-specific immunoregulation and the immunodeficiency of aging

Speck, N.A.; Pierce, S.K., 1982:
Antibody-specific immunoregulation is restricted by the major histocompatibility gene complex

Pierce, S.K.; Speck, N.A., 1983 :
Antibody-specific regulation of primary and secondary B-cell responses

Petrov, R.V.; Zhdanov, V.M.; Khaitov, R.M.; Norimov, A.Sh.; Nekrasov, A.V., 1984:
Antibody-stimulating and protective effect of a conjugate of the influenza virus M protein with a synthetic polymer

Pietersz, G.A.; Krauer, K., 1994:
Antibody-targeted drugs for the therapy of cancer

Heath, T.D.; Montgomery, J.A.; Piper, J.R.; Papahadjopoulos, D., 1983:
Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate

Strong, L.; Yarmush, D.M.; Yarmush, M.L., 1994:
Antibody-targeted photolysis. Photophysical, biochemical, and pharmacokinetic properties of antibacterial conjugates

McIntosh, D.P., 1984:
Antibody-toxin conjugates: a new approach to cancer therapy

Kraft, D.; Stemberger, H.; Wiedermann, G., 1974:
Antibody-types in drug allergies

Tompkin, R.B.; Christiansen, L.N.; Shaparis, A.B., 1980:
Antibotulinal efficacy of sulfur dioxide in meat

Provost, A.; Borredon, C.; Maurice, Y., 1967:
Antibovipestic protection conferred to cattle by a measles virus adapted to bovine cells

Oya, H., 1969:
Antibradykinin action of some drugs and mechanism of venoconstrictive action of bradykinin in the rabbit

Gaponiuk, P.Ia., 1967 :
Antibradykinin effect of dimedrol

Ryberg, B., 1982:
Antibrain antibodies in multiple sclerosis. Relation to clinical variables

Hermansen, K., 1970:
Antibrillatory effect of some beta-adrenergic receptor blocking agents determined by a new test procedure in mice

Davies, G.E., 1973:
Antibronchoconstrictor activity of two new phosphodiesterase inhibitors, a triazolopyrazine (ICI 58 301) and a triazolopyrimidine (ICI 63 197)

Corvol, P.; Banzet, O.; Thibonnier, M.; Elkik, F.; Menard, J.; Alexandre, J.M.; Milliez, P., 1981:
Anticalcium agents : new antihypertensive agents?

McNeal, D.R., 1969:
Anticalculus agents for the treatment, control, and prevention of periodontal disease

Banoczy, J.; Sari, K.; Schiff, T.; Petrone, M.; Davies, R., 1995:
Anticalculus efficacy of three dentifrices

Yeh, S.D., 1973:
Anticancer Chinese herbal medicines

el-Merzabani, M.M.; Sakurai, Y., 1967:
Anticancer activities of methanesulfonic acid esters of aminoglycols against mouse leukemia L-1210

Danopoulos, E.D.; Danopoulou, I.E., 1983:
Anticancer activity in urea

Ujiie, T., 1974:
Anticancer activity of 2-(2-(5-nitro-2-furyl)vinyl)-8-(beta-(N,N-diethylamino)ethoxy)quinoline

Noell, C.W.; Cheng, C.C., 1968:
Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds

Oberley, L.W.; Leuthauser, S.W.; Pasternack, R.F.; Oberley, T.D.; Schutt, L.; Sorenson, J.R., 1984:
Anticancer activity of metal compounds with superoxide dismutase activity

Furusawa, E.; Suzuki, N.; Tani, S.; Furusawa, S.; Ishioka, G.Y.; Motobu, J., 1973:
Anticancer activity of narcissus extracts in mice

Fiebig, H.H.; Eisenbrand, G.; Zeller, W.J.; Zentgraf, R., 1980:
Anticancer activity of new nitrosoureas against Walder carcinosarcoma 256 and DMBA-induced mammary cancer of the rat

Orita, K., 1973:
Anticancer activity of regional lymphnodes

Chitnis, M.P.; Khandalekar, D.D.; Adwankar, M.K.; Sahasrabudhe, M.B., 1971:
Anticancer activity of the extracts of root, stem & leaf of Ervatamia heyneana

Leopold, W.R.; Shillis, J.L.; Mertus, A.E.; Nelson, J.M.; Roberts, B.J.; Jackson, R.C., 1984:
Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues

Quinn, R.J.; Kashiwagi, M.; Moore, R.E.; Norton, T.R., 1974:
Anticancer activity of zoanthids and the associated toxin, palytoxin, against Ehrlich ascites tumor and P-388 lymphocytic leukemia in mice

Kinnamon, K.E.; Steck, E.A.; Rane, D.S., 1980:
Anticancer agents and antitrypanosomiasis activity in mice

Twomey, D., 1974:
Anticancer agents--IX. Derivatives of pyridine, pyridazine and phthalazine

O'Callaghan, C.N., 1974:
Anticancer agents--X. Cyclisation of 1-acyl-4-alkylthiosemicarbazide derivatives to 1,2,4-triazoline-3-thiones in the presence of hydrazine

Barry, V.C.; Conalty, M.L.; O'Callaghan, C.N.; Twomey, D., 1967:
Anticancer agents. 3. Synthesis and anticancer activity of some bis-thiosemicarbazones and thiosemicarbazides

O'Callaghan, C.N., 1973:
Anticancer agents. 8. Synthesis of substituted benzopyrano-(2,3-d) pyrimidines from 3-carbamoyl-2-iminochromens

Barry, V.C.; Conalty, M.L.; McCormick, J.E.; McElhinney, R.S.; McInerney, M.R.; O'Sullivan, J.F., 1970:
Anticancer agents. IV. The antitumor activity of some 1,4- and 1,5-(bisthiosemicarbazones) and of related heterocycles

Byrne, J.; O'Sullivan, J.F., 1972:
Anticancer agents. VII. Derivatives of pyruvaldehyde and ethylpyruvaldehyde

Oppelt, W.W., 1968:
Anticancer and immunosuppressive agents

Inoue, H.; Miyazono, N.; Kanetsuki, I.; Hori, A.; Tanaka, D.; Fukukura, Y.; Matsumoto, Y.; Nishida, H.; Ueno, K.; Nakajo, M., 1993:
Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma

Kelley, M.J.; Mulshine, J.L., 1994:
Anticancer antibodies for lung cancer

Nio, Y.; Tamura, K.; Tsubono, M.; Kawabata, K.; Masai, Y.; Hayashi, H.; Ishigami, S.; Araya, S.; Imamura, M., 1995:
Anticancer chemosensitivity changes between the original and recurrent tumors after successful chemotherapy selected according to the sensitivity assay

Henderson, I.W., 1967:
Anticancer chemotherapy

Coninx, P.; Lachapelle, F.; Pirenne, Y., 1971:
Anticancer chemotherapy and its place in the treatment of cancer

Miyake, H.; Suzuki, Y.; Kunishige, N., 1972:
Anticancer chemotherapy apropos of bleomycin

Durand, M., 1981:
Anticancer chemotherapy at home

Haguenauer, J.P., 1968:
Anticancer chemotherapy in cervicofacial pathology

Poch Viñals, R., 1982:
Anticancer chemotherapy in otorhinolaryngology (personal experience)

Saito, T., 1968:
Anticancer chemotherapy with evaluation of combined treatments

Chauvergne, J.; Lagarde, C., 1967:
Anticancer chemotherapy with rubidomycin (preliminary note on 14 cases

Rodman, M.J., 1972:
Anticancer chemotherapy. 2. Against solid malignant tumors

Rodman, M.J., 1972:
Anticancer chemotherapy. 3. Against the leukemias and lymphomas

Moulin, B.; Fillastre, J.P.; Godin, M.; Chantrel, F., 1995:
Anticancer chemotherapy. Prescription in the presence of renal insufficiency

Rodman, M.J., 1972:
Anticancer chemotherapy: 1. The kinds of drugs and what they do

Bahner, C.T.; Bingham, N.H.; Brotherton, D.H.; Cline, J.; Darby, D.; Harmon, H.D.; Rives, L.M.; Stump, B.L.; Watson, S.L., 1973:
Anticancer compounds. Further analogs of 1-(4-dimethylaminobenzylidene)indene

Muggia, F.M., 1981:
Anticancer drug development and federal regulation: protection against progress?

Carter, S.K., 1974:
Anticancer drug development programs: a comparison of approaches in the United States, the Soviet Union, Japan, and Western Europe

Carter, S.K.; Stringfellow, D., 1984:
Anticancer drug development--a challenge for industry and government

Hisazumi, H.; Uchibayashi, T.; Katoh, M.; Kobayashi, T.; Nakajima, K.; Naitoh, K.; Misaki, T.; Kuroda, K., 1981:
Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer

Hiraki, S.; Ohnoshi, T.; Miyai, M.; Numata, T.; Kishimoto, N.; Miyamoto, H.; Kimura, I., 1984:
Anticancer drug sensitivity tested by tumor stem cell assay

Anonymous, 1970:
Anticancer drug therapy

Hellman, K., 1972:
Anticancer drugs

Wu, P.C.; Ozols, R.F.; Hatanaka, M.; Boone, C.W., 1982:
Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar

Hamada, S., 1982:
Anticancer effect of levamisole and tegafur on 1,2-dimethylhydrazine (DMH)-induced colonic cancers in rats

Nakanishi, Y.; Hata, Y.; Sato, N.; Kawamura, A.; Uemura, T.; Hasegawa, M.; Miyakawa, K.; Nakamura, T.; Kawai, M.; Kawamoto, K., 1984:
Anticancer effect of peplomycin on advanced recurrent breast cancer

Saito, M.; Aonuma, E.; Noda, T.; Nakadate, I.; Nanjo, M.; Ebina, T.; Ishida, N., 1983:
Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432

Apple, M.A.; Cline, M.J., 1971:
Anticancer effects of propanals: comparison between human and animal tumor systems

Yamamura, Y., 1981:
Anticancer immunity and cancer immunotherapy with cell wall skeleton and related synthetic compounds

Mukhopadhyay, S.; Handy, G.A.; Funayama, S.; Cordell, G.A., 1981:
Anticancer indole alkaloids of Rhazya stricta

Eisenbrand, G., 1984:
Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities

Bernard, E., 1968:
Anticancer polychemotherapy

Israel, L., 1968:
Anticancer polychemotherapy of human tumors. Theoretical and practical problems

Téllez-Martínez, J.; García-Cavazos, R.; Yáñez, R.; González-Diddi, M., 1983:
Anticancer potentiality of three new synthetic nitrogen mustards

Lee, K.; Uchida, T.; Koshiba, K.; Shoji, K.; Egawa, S.; Fukuda, Y., 1983:
Anticancer regimen combined with methylprednisolone--its antiemetic effect

Hirt, B., 1981:
Anticancer research

Bleiberg, H.; Rozencweig, M.; Kenis, Y., 1981:
Anticancer therapy of carcinoid tumours

Ariel, I.M., 1974:
Anticancer therapy with hydrea: comparative study of daily vs. intermittent oral dosage

Caldarola, L., 1972:
Anticancer therapy: the year was not lost

Gerard, G., 1972:
Anticancer treatment and bromelains

Prescott, L.M., 1983:
Anticancer treatments can fight arthritic disorders

Faure, J.; Michel, B.; Yacoub, M.; Rouziou, J.M., 1973:
Anticancerous action of emetine. Toxicologic note

Pavlik, S.O.; Shpileva, L.D., 1969:
Anticandida preparation ammonium caprylate

Bilich, B.E.; Cherkasov, V.M.; Vladimirtsev, I.F., 1970:
Anticandida properties of certain derivatives of beta-nitrostyrene

Ti, J.S.; Steinfeld, A.S.; Naider, F.; Gulumoglu, A.; Lewis, S.V.; Becker, J.M., 1980:
Anticandidal activity of pyrimidine-peptide conjugates

Whitney, J.G.; Funderburk, S.S.; Westhead, J.E.; Lively, D.H.; Solenberg, J.M.; Denney, J.W., 1972:
Anticapsin, a new biologically active metabolite: screening and assay procedures

Chmara, H.; Zähner, H.; Borowski, E., 1984:
Anticapsin, an active-site directed irreversible inhibitor of glucosamine-6-phosphate synthetase from Escherichia coli

Falk, H.L., 1971:
Anticarcinogenesis--an alternative

Sugano, N.; Hibino, Y.; Choji, Y.; Maeda, H., 1982:
Anticarcinogenic actions of water-soluble and alcohol-insoluble fractions from culture medium of Lentinus edodes mycelia

DiGiovanni, J.; Rymer, J.; Slaga, T.J.; Boutwell, R.K., 1982:
Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons

Cho-Chung, Y.S.; Clair, T.; Shepheard, C., 1983:
Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase

Yun, T.K.; Yun, Y.S.; Han, I.W., 1983:
Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens

Ip, C.; Sinha, D., 1981:
Anticarcinogenic effect of selenium in rats treated with dimethylbenz[a]anthracene and fed different levels and types of fat

Bernal, S.D.; Lampidis, T.J.; McIsaac, R.M.; Chen, L.B., 1983:
Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye

Chorzelski, T.; Kuch, J., 1968:
Anticardiac antibodies and "pemphigus" autoantibodies in a patient with pemphigus and myocardial infarction

Sharma, S.S.; Kumar, S.; Kunwar, K.B.; Mehrotra, R.M.; Chaturvedi, U.C.; Mitra, M.K., 1970:
Anticardiac antibodies in ischaemic heart disease

Krister, E.E.; Tydel'skaia, I.L.; Goldina, V.V.; Myslavskaia, I.S., 1971:
Anticardiac antibodies in the blood of patients with myocardial infarct

Gisler, R.; Pillot, J., 1968:
Anticardiolipin activity linked to a Waldenstrom macroglobulin-cryoprecipitant IgG complex

Muir, K.W.; Squire, I.B., 1995:
Anticardiolipin antibodies (aCL) in patients following acute stroke

Koike, T., 1994:
Anticardiolipin antibodies and beta 2-glycoprotein I

Muir, K.W., 1995:
Anticardiolipin antibodies and cardiovascular disease

Harris, E.N.; Loizou, S.; Englert, H.; Derue, G.; Chan, J.K.; Gharavi, A.E.; Hughes, G.R., 1984:
Anticardiolipin antibodies and lupus anticoagulant

Fialová, L.; Mikulíková, L.; Janousek, M.; Cerný, V.; Malbohan, I., 1995 :
Anticardiolipin antibodies and oncofetal antigens in pregnant women

de la Fuente Fernandez, R.; Graña Gil, J., 1994:
Anticardiolipin antibodies and polyarteritis nodosa

Koike, T., 1994:
Anticardiolipin antibodies in NZW x BXSB F1 mice

Díez, J.J.; Doforno, R.A.; Iglesias, P.; Sastre, J.; Gómez-Pan, A.; Borbujo, J., 1993:
Anticardiolipin antibodies in autoimmune thyroid disease

Hojnik, M.; Gilburd, B.; Ziporen, L.; Blank, M.; Tomer, Y.; Scheinberg, M.A.; Tincani, A.; Rozman, B.; Shoenfeld, Y., 1994:
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy

Thawani, G.; Bhatia, V.N.; Mukherjee, A., 1994:
Anticardiolipin antibodies in leprosy

González Domínguez, J.; Ortega, C.; Jurado, R.; Muñoz, M.L.; Torre-Cisneros, J.; Kindelan, J.M.; Santamaría, M., 1995:
Anticardiolipin antibodies in parenteral drug addicts: relationship with HIV

Ramakrishna, R.; Manoharan, A., 1995:
Anticardiolipin antibodies in patients with angioimmunoblastic lymphadenopathy with dysproteinaemia

Thornton, J.G.; Scott, J.S.; Tovey, L.A., 1984:
Anticardiolipin antibodies in pregnancy

Bertram, B.; Haase, G.; Remky, A.; Reim, M., 1994:
Anticardiolipin antibodies in vascular occlusions of the eye

Matsuura, E.; Igarashi, Y.; Yasuda, T.; Triplett, D.A.; Koike, T., 1994:
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

Ruffatti, A.; DiLenardo, L.; Simioni, P.; Tonetto, S.; Girolami, A.; Grella, P.; Todesco, S., 1995:
Anticardiolipin antibodies, functional protein S deficiency, and fetal loss

Reyes, P.A.; Amigo, M.C.; Bañales, J.L.; Nava, A., 1994:
Anticardiolipin antibodies, rheumatic fever and rheumatic heart disease

Harris, E.N.; Gharavi, A.E.; Boey, M.L.; Patel, B.M.; Mackworth-Young, C.G.; Loizou, S.; Hughes, G.R., 1983:
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

Harris, E.N.; Pierangeli, S., 1994:
Anticardiolipin antibodies: specificity and function

Prakash, R.; Miller, C.C.; Suki, W.N., 1995:
Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis

Greaves, M., 1994:
Anticardiolipin in stroke

Schuster, G.S.; Dirksen, T.R.; Ciarlone, A.E.; Burnett, G.W.; Reynolds, M.T.; Lankford, M.T., 1980:
Anticaries and antiplaque potential of free-fatty acids in vitro and in vivo

Eklund, S.A.; Striffler, D.F., 1980:
Anticaries effect of various concentrations of fluoride in drinking water: evaluation of empirical evidence

Ciani, A., 1982 :
Anticaries efficacy in fluoride prevention

Canton, A., 1968:
Anticaries fluoroprophylaxis in the community of Sondalo (Sondrio). (Preliminary note)

Goaz, P.W.; McElwaine, L.P.; Biswell, H.A.; White, W.E., 1966:
Anticariogenic effect of a sodium monofluorophosphate solution in children after 21 months of use

Richardson, A.S.; Hole, L.W.; McCombie, F.; Kolthammer, J., 1972:
Anticariogenic effect of dicalcium phosphate dihydrate chewing gum: results after two years

Roukema, P.A., 1981:
Anticariogenic effects of saliva

Rosen, S.; Elvin-Lewis, M.; Beck, F.M.; Beck, E.X., 1984:
Anticariogenic effects of tea in rats

Reynolds, E.C.; Cain, C.J.; Webber, F.L.; Black, C.L.; Riley, P.F.; Johnson, I.H.; Perich, J.W., 1995:
Anticariogenicity of calcium phosphate complexes of tryptic casein phosphopeptides in the rat

Albanese, A.A., 1968:
Anticatabolic applications of newer anabolic steroids

Marchesini, G.; Zoli, M.; Dondi, C.; Bianchi, G.; Cirulli, M.; Pisi, E., 1982:
Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis

Stallion, A.; Foley-Nelson, T.; Chance, W.T.; James, J.H.; Fischer, J.E., 1995:
Anticatabolic effect of the beta 2-agonist cimaterol in vivo in tumor-bearing animals

Laube, H.; Burckhardt, H.; Greiner, P.; Goberna, R.; Fussgänger, R.; Pfeiffer, E.F., 1971:
Anticatabolic effects of methyltestosterone in DHT-induced progeria-like syndrome

Pelosi, G.; Proietti, R.; Magalini, S.I.; Santori, R.; Giammaria, A.; Manni, C., 1983:
Anticatabolic properties of branched chain amino acids in trauma

Ceriotti, G.; Spandrio, L.; Agradi, A., 1965:
Anticatalase action in vitro and in vivo of cysteine, tyrosine and some related compounds in relation to the anticatalase activity of tumors

Zetler, G., 1970:
Anticataleptic actions of amantadine hydrochloride

Ke, P.J.; Thibert, R.J., 1973:
Anticatalytic microdetermination of mercury using cerium-arsenite reaction

Selye, H., 1972:
Anticatatoxic hormones

Pokidysheva, L.N.; Gulevich, N.E.; Lavrukhina, L.A., 1982:
Anticellular action of alpha-interferons of various origins

Hovanessian, A.G.; Wood, J.N., 1980:
Anticellular and antiviral effects of pppA(2'p5'A)n

Fossati, G.C.; Barigazzi, G.; Bonizzoni, D.; Ruberto, M., 1969:
Anticellular effects of Salmonella abortus equi lipopolysaccharides. Studies on erythropoietic chick embryo cells

Tuffanelli, D.L.; McKeon, F.; Kleinsmith, D.M.; Burnham, T.K.; Kirschner, M., 1983:
Anticentromere and anticentriole antibodies in the scleroderma spectrum

Makinen, D.; Fritzler, M.; Davis, P.; Sherlock, S., 1983:
Anticentromere antibodies in primary biliary cirrhosis

Meyer, O.; Haïm, T., 1982:
Anticentromere antibodies. Diagnostic and prognostic value

Fritzler, M.J.; Ayer, L.M., 1982:
Anticentromere antibodies: clinical and biological significance

Seibold, J.R.; Trontell, M.C., 1982:
Anticentromere antibody and primary pulmonary hypertension

Bernstein, R.M.; Asherson, R.A.; Oakley, C.M.; Hughes, G.R., 1984:
Anticentromere antibody and pulmonary hypertension

Bernstein, R.M.; Callender, M.E.; Neuberger, J.M.; Hughes, G.R.; Williams, R., 1982:
Anticentromere antibody in primary biliary cirrhosis

Caramaschi, P.; Biasi, D.; Manzo, T.; Carletto, A.; Poli, F.; Bambara, L.M., 1995:
Anticentromere antibody--clinical associations. A study of 44 patients

McCarty, G.A.; Rice, J.R.; Bembe, M.L.; Barada, F.A., 1983:
Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants

Oleĭnik, V.A., 1985:
Anticerebral antibodies in post-thyrotoxic encephalo-ophthalmopathy

Semenov, S.F.; Chuprikov, A.P.; Kokhanov, V.P., 1968:
Anticerebral antibodies in pregnant women with brain pathology and in their newborn infants

Jansén, C.T.; Hollmén, A.; Pajarre, R.; Terho, P., 1980:
Antichlamydial antibodies in chronic palmoplantar pustulosis

Hahn, D.L., 1995:
Antichlamydial antimicrobial therapy for asthma

Gallut, J.; Lapeyssonie, L., 1970:
Anticholera vaccination by intradermal route

Diop Mar, I.; Sarrat, H.; Robin, Y.; Oudart; Rey, M., 1971:
Anticholera vaccination by means of the intradermal pedojet. Clinical and immunologic response (results of a Senegalese experiment)

Fedorovskaia, E.A.; Lobunets, K.A.; Babiĭ, Z.N.; Akimov, V.Ia., 1973:
Anticholeraic gamma globulin from the blood plasma of immune donors

Magnusson, I., 1984:
Anticholeretic effects of substance P and somatostatin

Brestkin, A.P.; Bink, I.L.; Volkova, R.I.; Godovikov, N.N.; Kabachnik, M.I.; Teplov, N.E., 1965:
Anticholesterase properties of O,O-diethyl-S-[(beta-aryl-methylamino)-ethyl]-thiophosphates and their methylsulfomethylates

Anonymous, 1995:
Anticholinergic Therapy for Allergic and Nonallergic Rhinitis and the Common Cold, Symposium proceedings. Aspen, Colorado, August 1994

Hadházy, P., 1972:
Anticholinergic action of aminophylline in isolated guinea-pig atria

Alvarez Gonzalez, F.J.; Carvajal Garcia-Pando, A.; Casas Gonzalez, M.T.; Gonzalez Martinez de Zarate, J.L.; Velasco Martin, A., 1984:
Anticholinergic action of neuroleptics and antidepressives on the guinea pig ileum. Comparison with atropine and pirenzepine

Ojewole, J.A., 1983:
Anticholinergic action of pirenzepine (Gastrozepin) on isolated gastrointestinal tract smooth muscles

Tang, A.H.; Schroeder, L.A., 1969:
Anticholinergic activities of imipramine and methylphenidate

Iisalo, E.; Aaltonen, L., 1984:
Anticholinergic activity in the serum of patients receiving maintenance disopyramide therapy

Petersen, R.C.; Richelson, E., 1982:
Anticholinergic activity of imipramine and some analogs at muscarinic receptors of cultured mouse neuroblastoma cells

Casas González, M.T.; Carvajal García-Pando, A.; Velasco Martín, A.; Gonzalez Martínez de Zárate, J.L., 1983:
Anticholinergic activity of neuroleptics and antidepressants in guinea pig intestine stimulated electrically

Ulmer, W.T.; Dorsch, J.; Iravani, J.; Schüler, K.G.; Stempel, G.; Vastag, E., 1973:
Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction

Stubbins, J.F.; Hudgins, P.M.; Andrako, J.; Beebe, A.J., 1968:
Anticholinergic agents based on Ariens' dual receptor site theory

Stubbins, J.F.; Hudgins, P.M.; Murphy, D.C.; Dickerson, T.L., 1972:
Anticholinergic agents based on Ariëns' dual receptor site theory: nonester antagonists

Folco, G.; Omini, C.; Rossoni, G.; Viganò, T.; Berti, F., 1982:
Anticholinergic agents prevent guinea-pig airway constriction induced by histamine, bradykinin and leukotriene C4: Relationship to circulating TXA2

Gonzálvez Sánchez, J.A.; Hernández Bravo, M.T.; Cerda Olmedo, G.; Iborra García, R.; Iborra García G [corrected to Iborra García, R.]., 1994:
Anticholinergic agents with gastrointestinal selectivity: are they really selective?

Landmark, K.; Refsum, H., 1973:
Anticholinergic and anti-arrhythmic effects of phenoxybenzamine on the isolated rat atrium

Del Vecchio-Blanco, C.; Stroffolini, T., 1981:
Anticholinergic and benzodiazepine drugs in the therapy of functional colonic diseases

Husted, S.; Andersson, K.E.; Sommer, L.; Ostergaard, J.R., 1980:
Anticholinergic and calcium antagonistic effects of terodiline in rabbit urinary bladder

Rebuck, A.S.; Gent, M.; Chapman, K.R., 1983:
Anticholinergic and sympathomimetic combination therapy of asthma

Janowsky, D.; Drennan, M.; Berkowitz, A.; Turken, A.; Risch, S.C., 1984:
Anticholinergic antagonism of cholinesterase inhibitor lethality

Burks, C.D.; Fisher, A.E., 1970:
Anticholinergic blockade of schedule-induced polydipsia

Alanko, K.; Poppius, H., 1973:
Anticholinergic blocking of prostaglandin-induced bronchoconstriction

Block, M.L.; Fisher, A.E., 1970:
Anticholinergic central blockade of salt-aroused and deprivation-induced drinking

Kaumeier, S., 1984:
Anticholinergic crisis

Gulmann, N.C.; Kristensen, M.O., 1984:
Anticholinergic delirium in patients with dementia. Senile dementia - a contraindication for treatment with anticholinergic agents

Sperling, W.; Mösler, T., 1995:
Anticholinergic delirium--diagnosis and therapy

Pullen, G.P.; Best, N.R.; Maguire, J., 1984:
Anticholinergic drug abuse: a common problem?

Schapiro, H.; Wruble, L.D.; Estes, J.W.; Sherman, R.; Britt, L.G., 1968:
Anticholinergic drug action on pancreatic exocrine outflow in man and dog

Gravgaard, E., 1966:
Anticholinergic drug treatment of duodenal ulcer and gastroduodenitis with glycopyrrone

Itil, T.; Fink, M., 1966:
Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations

Itil, T.M., 1969:
Anticholinergic drug-induced sleep-like EEG pattern in man

Wikler, A., 1968:
Anticholinergic drugs and brain functions in animals and man. Introduction

Anderson, G., 1983:
Anticholinergic drugs in airways obstruction

Kaye, M.D., 1972:
Anticholinergic drugs in duodenal ulcer

Anonymous, 1966:
Anticholinergic drugs in peptic ulceration

Amure, B.O., 1965:
Anticholinergic drugs in the management of duodenal ulcer

Hughes, R.A., 1982:
Anticholinergic drugs, blood-brain-barrier and tonic immobility in chickens

Fusek, J.; Kabes, J.; Fink, Z., 1972:
Anticholinergic effect of 3-quinuclidyl benzilate

Pantio, M.; Saarimaa, H.; Strandman, D., 1971:
Anticholinergic effect of tropenzilinium and oxyphencyclimine

Schapiro, H.; Wruble, L.D., 1969:
Anticholinergic effect on exocrine pancreatic secretion

Pomeroy, A.R.; Rand, M.J., 1969:
Anticholinergic effects and passage through the intestinal wall of N-butylhyoscine bromide

Ehrhart, G.; Härtfelder, G.; Schmitt, K., 1970:
Anticholinergic effects depending on the chemical constitution of a series of tertiary and quaternary propylamine derivatives

Huszonek, J.J., 1995:
Anticholinergic effects in a depressed parkinsonian patient

Mirro, M.J.; Manalan, A.S.; Bailey, J.C.; Watanabe, A.M., 1980:
Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade

Hill, D.G.; Jansen, A.B., 1969:
Anticholinergic esters of 2,6-bis (methoxymethyl) pirid-4-ol

Carrano, R.A.; Malone, M.H., 1966:
Anticholinergic evaluation of 1,1-diphenyl-2-(1-methyl-3-pyrrolidyl) ethanol and N-(2'5'-dimethyl-1'-piperidylmethyl) benzilamide

Longo, V.G.; Scotti de Carolis, A., 1968:
Anticholinergic hallucinogenics: laboratory results versus clinical trials

Spradlin, W.W.; Sternbergh, W.C.; Wilson, W.P.; Hughes, J.L., 1965:
Anticholinergic hallucinosis. I. Effect of atropine and JB-329 on "caudate spindle" phenomena and electrical activity of cat hippocampus. Panel discussion

Sternbergh, W.C.; Wilson, W.P., 1965:
Anticholinergic hallucinosis. II. Effects of atropine and JB-329 on activity of the visual system, nonsepcific projection system, and hippocampus in animals with and without reticular system lesions. Panel discussion

Lazenby, G.W.; Reed, J.W.; Grant, W.M., 1970:
Anticholinergic medication in open-angle glaucoma. Long-term tests

Gitsch, E.; Holzner, H., 1967:
Anticholinergic modification of the ovary in animal experiments

Goldfrank, L.; Flomenbaum, N.; Lewin, N.; Weisman, R.; Howland, M.A.; Kaul, B., 1982:
Anticholinergic poisoning

Rumack, B.H., 1973:
Anticholinergic poisoning: treatment with physostigmine

Rhoads, P.M.; Tong, T.G.; Banner, W.; Anderson, R., 1984:
Anticholinergic poisonings associated with commercial burdock root tea

Hirschowitz, B.I.; Molina, E., 1983:
Anticholinergic potency of diphenhydramine (Benadryl) measured against bethanechol in the gastric fistula dog

Ray, O.S.; Bivens, L.W., 1968:
Anticholinergic potentiation of amphetamine: reinforcement schedule effects

Cotton, B.R.; Smith, G., 1981:
Anticholinergic premedication and regurgitation

Blanc, V.F., 1983:
Anticholinergic premedication for infants and children (the oculocardiac reflex)

Cozanitis, D.A.; Jones, C.J.; Erkola, O., 1984:
Anticholinergic premedication in infants: a comparison of atropine and glycopyrrolate on heart rate, demeanor, and facial flushing

Chisakuta, A.M.; Mirakhur, R.K., 1995:
Anticholinergic prophylaxis does not prevent emesis following strabismus surgery in children

Makabe, R., 1973:
Anticholinergic psychopharmacological agents and glaucoma

Hvizdos, A.J.; Bennett, J.A.; Wells, B.G.; Rappaport, K.B.; Mendel, S.A., 1983:
Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine

Hall, R.C.; Feinsilver, D.L.; Holt, R.E., 1981:
Anticholinergic psychosis: differential diagnosis and management

Prendergast, M.D.; Nasca, T.J., 1984:
Anticholinergic syndrome with procainamide toxicity

Marchlewski, M.B., 1994:
Anticholinergic syndrome. Avoiding misdiagnosis

Geiger-Bronsky, M.J., 1995:
Anticholinergic therapy in the critically ill patient with bronchospasm

Rebuck, A.S.; Chapman, K.R.; Braude, A.C., 1982:
Anticholinergic therapy of asthma

Dotevall, G.; Walan, A., 1971:
Anticholinergic therapy of gastric ulcers

Woody, G.E.; O'Brien, C.P., 1974:
Anticholinergic toxic psychosis in drug abusers treated with benztropine

Catterson, M.L.; Martin, R.L., 1994:
Anticholinergic toxicity masquerading as neuroleptic malignant syndrome: a case report and review

Schultze-Werninghaus, G., 1981:
Anticholinergic versus beta 2-adrenergic therapy in allergic airways obstruction: double-blind trials on bronchodilator effect and antiallergic protection of oxitropium bromide and fenoterol

Horrocks, P.M.; Vicary, D.J.; Rees, J.E.; Parkes, J.D.; Marsden, C.D., 1973:
Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease

Gross, N.J.; Skorodin, M.S., 1984:
Anticholinergic, antimuscarinic bronchodilators

Ferrucci, J.T.; Benedict, K.T., 1971:
Anticholinergic-aided study of the gastrointestinal tract

Heppner, F.; Argyropoulos, G.; Lanner, G., 1973:
Anticholinergical treatment of brain injury. Results of 2 decades

Haffner, J., 1974:
Anticholinergics

Anonymous, 1970:
Anticholinergics and duodenal ulcer

Linazasoro, G., 1994:
Anticholinergics and dyskinesia

Tanner, C.; Goetz, C.G.; Weiner, W.J., 1980:
Anticholinergics and tardive dyskinesia

Gever, L.N., 1984:
Anticholinergics and what to teach your patient about them

Hurtig, H.I., 1980:
Anticholinergics for Parkinson disease

Londong, W., 1982:
Anticholinergics for peptic ulcer--a renaissance?

Belker, A.M., 1973:
Anticholinergics for the uninhibited neurogenic bladder

Lang, A.E.; Sheehy, M.P.; Marsden, C.D., 1982:
Anticholinergics in adult-onset focal dystonia

Borison, R.L.; Diamond, B.I., 1980:
Anticholinergics promote neuroleptic-induced tardive dyskinesia

George, R.B.; Payne, D.K., 1984:
Anticholinergics, cromolyn, and other occasionally useful drugs

Yun, L.H.; Wen, G.I.; Zhang, Q.K., 1984:
Anticholinergics: synthesis of 2',2'-diphenylethyl azacycloalkane derivatives

Wang, X.M.; Yun, L.H.; Wen, G.L.; Zhang, Q.K., 1984:
Anticholinergics: synthesis of alpha and beta isomers of 3-methyl-3-azabicyclo [3, 3, 1] nonan-9-yl esters

Houser, V.P.; Paré, W.P., 1974:
Anticholinergics: their effects on fear-motivated behavior, urinary 11-hydroxycorticosteroids, urinary volume, and heart rate in the dog

Baraka, A., 1982:
Anticholinergics: when, which, why?

Dufour, P.; Roquebert, J.; Canellas, J.; Courtois, P., 1973:
Anticholinesteras activity of central analgesics

Munsat, T.L., 1984:
Anticholinesterase abuse in myasthenia gravis

Yamane, M.; Abe, A.; Yanagisawa, I., 1984:
Anticholinesterase action of a bromine compound isolated from human cerebrospinal fluid

Ivanov, I.Ia.; Brel', V.K.; Martynov, I.V., 1984:
Anticholinesterase action of fluorochloronitroacetic acid esters

Benke, G.M.; Murphy, S.D., 1974:
Anticholinesterase action of methyl parathion, parathion and azinphosmethyl in mice and fish: onset and recovery of inhibition

Novgorodskaia, A.M.; Rozengart, V.I.; Shcherbak, I.G., 1971:
Anticholinesterase action of the organophosphorus compound LG-63 in vivo

Rose, J.A.; Voss, G., 1971:
Anticholinesterase activity and enzymatic degradation of phosphamidon and -chlorophosphamidon: a comparative study

Pesotskaia, G.V.; Petrenko, V.S.; Panasiuk, A.I.; Danchenko, M.N.; Kasukhin, L.F.; Gololobov, I.G., 1981:
Anticholinesterase activity and toxicity of substituted O,O-dialkyl-S-vinyl phosphates and thiovinyl phosphonium salts

Samoilov, D.N., 1971:
Anticholinesterase activity of bis-quaternary ammonium derivatives of truxillic acids

Bhattacharya, S.K.; Sanyal, A.K., 1971:
Anticholinesterase activity of bufotenine

Berezhinskaia, V.V.; Aleshinskaia, E.E.; Trutneva, E.A., 1968:
Anticholinesterase activity of some alkaloids of the isoquinoline group

Ali, H.I.; El-Mahdy, S.A.; Helmi, R.; Moustapha, M.; Radwan, A., 1973:
Anticholinesterase activity of some alpha-adrenergic blockers

Hemsworth, B.A.; West, G.B., 1970:
Anticholinesterase activity of some degradation products of physostigmine

Hacker, M.P.; Braddock, J.; Unwin, S., 1982:
Anticholinesterase activity of the unsymmetric bisquaternary 6-aminoquinoline salt NSC-176319

Fortes, Z.B.; Reis, C.C.; Scivoletto, R., 1980:
Anticholinesterase activity of tranylcypromine and its isomers

Szendey, G.L., 1972:
Anticholinesterase activity--studies on chemical models. 5. Symmetrical bisquarternary cyclic amines with a rigid interquarternary chain

Uono, K., 1970:
Anticholinesterase agents

Deutsch, J.A.; Rocklin, K., 1972:
Anticholinesterase amnesia as a function of massed or spaced retest

Livingston, A.; Sooriyamoorthy, T.; Griffin, J., 1974:
Anticholinesterase and hypotensive effects of some intravenous contrast media

Bevan, D.R.; Donati, F., 1983:
Anticholinesterase antagonism of succinylcholine phase II block

Mandel'shtam, I.E., 1967:
Anticholinesterase compound penetration into the nervous systems of Asiatic locusts

Ikonomoff, S.I., 1970:
Anticholinesterase drugs and epileptic seizures

Schott, G.D.; Loh, L., 1984:
Anticholinesterase drugs in the treatment of chronic pain

Chew, S.K.; Chew, L.S.; Wang, K.W.; Mah, P.K.; Tan, B.Y., 1984:
Anticholinesterase drugs in the treatment of tetrodotoxin poisoning

Kinyon, G.E., 1969:
Anticholinesterase eye drops--need for caution

Anonymous, 1966:
Anticholinesterase eyedrops in chronic simple glaucoma

Mackey, C.L., 1982:
Anticholinesterase insecticide poisoning

Chamberlain, W., 1974:
Anticholinesterase miotics in the management of accommodative esotropia

Sim, V.M., 1974:
Anticholinesterase poisoning

Mikhaĭlov, S.S., 1982:
Anticholinesterase properties and metabolism of new thiophosphonates with a carboxy ester bond in the phosphoryl portion of the molecule

Kuleshov, V.I.; Kozlov, N.S.; Libman, N.M.; Kosmacheva, I.M.; Zhikhareva, O.D., 1981:
Anticholinesterase properties of benzo(f)quinolinium derivatives

Sakai, K.; Akima, M.; Matsushita, H., 1972:
Anticholinesterase property of oxyfedrine

Malloy, S.E., 1981:
Anticipate the unforeseen: cardiac arrest

Robertson, L.S.; Kosa, J.; Alpert, J.J.; Heagarty, M.C., 1968:
Anticipated acceptance of neighborhood health clinics by the urban poor

Richard, R.; van der Pligt, J.; de Vries, N., 1995:
Anticipated affective reactions and prevention of AIDS

Pratt, C.C.; Kethley, A.J., 1980 :
Anticipated and actual barriers to developing community mental health programs for the elderly

Roghman, K.J.; Haggerty, R.J.; Lorenz, R., 1971:
Anticipated and actual effects of Medicaid on the medical-care pattern of children

Suedfeld, P., 1968:
Anticipated and experienced stress in sensory deprivation as a function of orientation and ordinal position

Gerdes, J.W., 1969:
Anticipated directions for the future of public general hospitals

Boerema, I., 1971:
Anticipated discharge from a surgical clinic

Cameron, C.T., 1968:
Anticipated disease--a new concept

Wigdorowicz-Makowerowa, N.; Plonka, B.; Potoczek, S.; Dadun-Sek, A., 1971:
Anticipated effects of drinking water fluoridation in Wroclaw on the caries prophylaxis in permanent dentition in children

Arrowood, A.J.; Ross, L., 1966:
Anticipated effort and subjective probability

Tryon, A.F.; Powell, E.; Roghmann, K., 1970:
Anticipated health behavior of families in relation to Medicaid

Conant, L.; Robertson, L.S.; Kosa, J.; Alpert, J.J., 1971:
Anticipated patient acceptance of new nursing roles and physicians' assistants

Schulze, G.; Inke, G., 1969:
Anticipated perforation points of periapical inflammatory processes on the human mandible

Veitch, P.C., 1995:
Anticipated response to three common injuries by rural and remote area residents

Biase, D.V.; Mitchell, J., 1969:
Anticipated responses to short-term sensory deprivation

Anonymous, 1983:
Anticipated revision of the law concerning public health clinics: revision of the financial support of public health clinics to a fixed sum allotment system (unit payment system)

Mitchell, C.M., 1974:
Anticipated revisions to the current good manufacturing practice regulations

Lefcourt, H.M.; Barnes, K.; Parke, R.; Schwartz, F., 1966:
Anticipated social censure and aggression-conflict as mediators of response to aggression induction

Gerber, R.M.; Hinshaw, A.S.; Atwood, J.R., 1983:
Anticipated turnover among nursing staff

Anonymous, 1970:
Anticipating a career

Perry, H.T., 1972:
Anticipating adolescent growth vectors and velocities

Orgel, L.E.; Crick, F.H.; Orgel, L.E.; Crick, H.C.; Orgel, L.E., 1993:
Anticipating an RNA world. Some past speculations on the origin of life: where are they today?

Holman, C.B., 1973:
Anticipating changes in neuroradiology

Harmon, G.; Victory, M.; Harvey, S., 1982:
Anticipating clinical information needs: preclinical primers for the clinical medical librarian

DuVal, M.K., 1965:
Anticipating community relationships

Koenig, R.R., 1969:
Anticipating death from cancer--physician and patient attitudes

Hazelrigg, C.O., 1982:
Anticipating drug interactions

Wolfson, J.J.; Engel, R.R., 1969:
Anticipating meconium peritonitis from metaphyseal bands

Voitk, A.J., 1974:
Anticipating pressure necrosis in intestinal obstruction

Finnberg, E.A., 1983:
Anticipating side effects of relaxation treatment

Tsonchev, I.; Andonova, S., 1974:
Anticipating suppression of ectopic disorders of cardiac rhythm

Small, I.F.; Small, J.G.; Poiner, V., 1966:
Anticipating the effects of program change

Polacsek, R.A., 1984:
Anticipating the future in medical computing

Couri, D., 1980:
Anticipating the hazards of worker self-medication

Davis, G., 1966:
Anticipating the questions helps prevent emergency room trouble

Anderson, J.G., 1972:
Anticipating the second-order consequences of health care programs

Mehren, G.L., 1968:
Anticipating the year 2000

Tenney, S.M., 1974:
Anticipating the "Bohr effect". An historical comment

Sondheimer, A., 1982:
Anticipation and experimentation: the sexual concerns of mid adolescence

Burke, D.; McKeon, B.; Skuse, N.F.; Westerman, R.A., 1980:
Anticipation and fusimotor activity in preparation for a voluntary contraction

Gray, K.C.; Williams, D.E., 1969:
Anticipation and stuttering: a pupillographic study

Le Marec, B.; Bourdiniere, J.; Jezequel, J.; Senecal, J., 1974:
Anticipation and the Franceschetti-Zwahlen-Klein syndrome

Arenberg, D., 1965:
Anticipation interval and age differences in verbal learning

Innocenzi, A.; Obialero, M., 1981:
Anticipation of a new method of additive mastoplasty with myo-dermal flap of the great dorsal muscle

Laska, E.; Sunshine, A., 1973:
Anticipation of analgesia. A placebo effect

Stanchev, I.N., 1984:
Anticipation of duodenal peptic ulcer. I. Prevention in subjects at risk of inheriting it

Papageorgis, D., 1967:
Anticipation of exposure to persuasive messages and belief change

Reynolds, D.K.; Kalish, R.A., 1974:
Anticipation of futurity as a function of ethnicity and age

Hilgard, E.R.; Macdonald, H.; Marshall, G.; Morgan, A.H., 1974:
Anticipation of pain and of pain control under hypnosis: heart rate and blood pressure responses in the cold pressor test

Lowney, E.D., 1969:
Anticipation of problems of systemic corticosteroid therapy

Naatanen, R., 1969:
Anticipation of relevant stimuli and evoked potentials: a reply to Donchin and Cohen

Donchin, E.; Cohen, L., 1969:
Anticipation of relevant stimuli and evoked potentials: a reply to Naatanen

Fraisse, P., 1966:
Anticipation of rhythmic stimuli. Speed of establishment and accuracy of synchronization

Luxereau, P.; Vahanian, A.; Ducimetière, P.; Caillet, D.; Garnier, D.; Acar, J., 1983:
Anticipation of surgical results in calcified aortic stenosis as a function of age

Vatter, O.; Denden, A., 1970:
Anticipation potentials in the visual cortex and frontal lobe

Blue, C.M., 1970:
Anticipation vs recall in the paired-associate learning of intellectually average and retarded subjects

Kishida, J., 1969:
Anticipations for 10 years from now. Living in the 21st Century

Block, I.R., 1980:
Anticipatory analgesia for pain following hemorrhoidectomy

Grings, W.W., 1969:
Anticipatory and preparatory electrodermal behavior in paired stimulation situations

Dinner, S.H.; Lewkowicz, B.E.; Cooper, J., 1972:
Anticipatory attitude change as a function of self-esteem and issue familiarity

McGuire, W.J.; Millman, S., 1965:
Anticipatory belief lowering following forewarning of a persuasive attack

Bonnet, M., 1983:
Anticipatory changes of long-latency stretch responses during preparation for directional hand movements

Martin, J.G.; Mills, C.B.; Meltzer, R.H.; Shields, J.H., 1980:
Anticipatory coarticulation and reaction time to phoneme targets in spontaneous speech

Moneyham, L.; Scott, C.B., 1995:
Anticipatory coping in the elderly

Davis, L.; Grace, H., 1971:
Anticipatory counseling of unwed pregnant adolescents

Bench, J., 1971:
Anticipatory elicitation of the middle-ear muscle reflex

Bolles, R.C., 1968:
Anticipatory general activity in thirsty rats

Clayton, P.J.; Halikas, J.A.; Maurice, W.L.; Robins, E., 1973:
Anticipatory grief and widowhood

Welch, D., 1982:
Anticipatory grief reactions in family members of adult patients

Fulton, R.; Gottesman, D.J., 1980:
Anticipatory grief: a psychosocial concept reconsidered

Tinnin, L.W.; Bridwell, M.W., 1972:
Anticipatory guidance for abortion

Kinsbourne, M.; Swanson, J.W., 1980:
Anticipatory guidance for classroom conduct and learning problems

Cavanaugh, R.M., 1994:
Anticipatory guidance for the adolescent: has it come of age?

Reisinger, K.S.; Bires, J.A., 1980:
Anticipatory guidance in pediatric practice

Broussard, A.B., 1984:
Anticipatory guidance. Adding solids to the infant's diet

O'Neal, K.J., 1993:
Anticipatory guidance: alcohol, adolescents, and recognizing abuse and dependence

Sroufe, L.A.; Sonies, B.C.; West, W.D.; Wright, F.S., 1973:
Anticipatory heart rate deceleration and reaction time in children with and without referral for learning disability

Sanders, R.M.; Wood, D.M., 1969:
Anticipatory heart-rate changes: environmental vs self-produced mediation of the time between a warning stimulus and the required response

Savich, P.A., 1984:
Anticipatory imagery ability in normal and language-disabled children

Lubker, J.; Gay, T., 1982:
Anticipatory labial coarticulation: experimental, biological, and linguistic variables

de Melker, R.A., 1984:
Anticipatory medicine

Weddington, W.W.; Miller, N.J.; Sweet, D.L., 1982:
Anticipatory nausea and vomiting associated with cancer chemotherapy

Morrow, G.R.; Arseneau, J.C.; Asbury, R.F.; Bennett, J.M.; Boros, L., 1982:
Anticipatory nausea and vomiting with chemotherapy

Moher, D.; Arthur, A.Z.; Pater, J.L., 1984:
Anticipatory nausea and/or vomiting

Baldwin, J.V., 1967:
Anticipatory pediatrics

Traub, M.M.; Rothwell, J.C.; Marsden, C.D., 1980:
Anticipatory postural reflexes in Parkinson's disease and other akinetic-rigid syndromes and in cerebellar ataxia

McLardy, T., 1971:
Anticipatory recall deficit after cingulumotomy in rats

D'Amato, M.R.; Fazzaro, J.; Etkin, M., 1968:
Anticipatory responding and avoidance discrimination as factors in avoidance conditioning

Saito, M.; Kato, H., 1982:
Anticipatory responses in behaviours and metabolism

Harvill, L.M., 1981:
Anticipatory socialization of medical students

Monat, A.; Averill, J.R.; Lazarus, R.S., 1972:
Anticipatory stress and coping reactions under various conditions of uncertainty

Demos, G.T.; Hale, H.B.; Williams, E.W., 1969:
Anticipatory stress and flight stress in F-102 pilots

Singh, I.L., 1984:
Anticipatory stress and vigilance

Robertson, A.D.; Youniss, J., 1969:
Anticipatory visual imagery in deaf and hearing children

Wilcox, P.M.; Fetting, J.H.; Nettesheim, K.M.; Abeloff, M.D., 1982:
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma

Naes, K., 1974:
Anticlimax for the new H2 antagonist

Thonnart, N.; Letist, D.; Reuse, J.J., 1973:
Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat

Denis, F.; Desmarest, M.C.; Boilleau, Y., 1970:
Anticoagulant action of cephaloridines. In vitro study in thrombelastography

Rudowski, W.; Kostrzewska, E.; Sawicki, F.; Klawe, Z., 1973:
Anticoagulant action of dextran

Hauptmann, J.; Kaiser, B.; Markwardt, F., 1985:
Anticoagulant action of synthetic tight binding inhibitors of thrombin in vitro and in vivo

Lane, D.A.; Denton, J.; Flynn, A.M.; Thunberg, L.; Lindahl, U., 1984:
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4

Bond, H.W.; Dedhiya, M.G.; Carlson, G.P., 1973:
Anticoagulant activities of some 2-acyl-1, 3-indandiones

Condrea, E.; Yang, C.C.; Rosenberg, P., 1983:
Anticoagulant activity and plasma phosphatidylserine hydrolysis by snake venom phospholipases A2

Rehse, K.; Tenczer, J., 1980:
Anticoagulant activity of 1,2-benzoxathiine derivatives

Allori, L.; Boumis, G.; Carassai, L., 1974:
Anticoagulant activity of Agkistrodon rhodostoma venom

Mishra, K.C.; Sharma, R.C.; Sharma, Y.N.; Arora, R.B., 1969:
Anticoagulant activity of Heraclenin

Sederel, L.C.; van der Does, L.; van Duijl, J.F.; Beugeling, T.; Bantjes, A., 1981:
Anticoagulant activity of a synthetic heparinoid in relation to molecular weight and N-sulfate content

Fougnot, C.; Dupillier, M.P.; Jozefowicz, M., 1983:
Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function

Bernstein, E.F.; Gans, H., 1966:
Anticoagulant activity of angiographic contrast media

Miura, Y.; Aoyagi, S.; Ikeda, F.; Miyamoto, K., 1980:
Anticoagulant activity of artificial biomedical materials with co-immobilized antithrombin III and heparin

Akiyama, F.; Seno, N.; Yoshida, K., 1982:
Anticoagulant activity of dermatan polysulfates

Mauzac, M.; Jozefonvicz, J., 1984:
Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization

Turner, D.L.; Holburn, R.R.; Silver, M.J.; Baczynski, E., 1972:
Anticoagulant activity of glycol analogs of phosphatidylserine

Ototani, N.; Yosizawa, Z., 1981:
Anticoagulant activity of heparin octasaccharide

Dezelić, M.; Trkovnik, M.; Jovanović, V.; Huković, S., 1965:
Anticoagulant activity of newly synthetized 6-fluoro-4-hydroxycoumarin derivatives

Whistler, R.L.; Kosik, M., 1971:
Anticoagulant activity of oxidized and N- and O-sulfated chitosan

Mende, T.J., 1970:
Anticoagulant activity of synthetic iodinated polypeptides

Gomez-Perez, F., 1972:
Anticoagulant activity of two commercially available heparin preparations. A controlled study

Abe, T.; Kazama, M.; Matsuda, M., 1965:
Anticoagulant activity of whale heparin and its characteristics

Abe, T.; Kazama, M.; Matsuda, M.; Ikemori, R.; Shibata, T., 1968:
Anticoagulant activity of whale intestine heparin and its clinical application

Cristea, E.; Mihail, S.; Murariu-Bogdan, M., 1983:
Anticoagulant and antifibrinolytic medication in ophthalmology

Scully, M.F.; Weerasinghe, K.M.; Ellis, V.; Djazaeri, B.; Kakkar, V.V., 1983:
Anticoagulant and antiheparin activities of a pentosan polysulphate

Teng, C.M.; Yeh, H.I.; Lee, L.G., 1983:
Anticoagulant and antiplatelet properties of piracetam

Hauptmann, J.; Kaiser, B.; Markwardt, F.; Nowak, G., 1980:
Anticoagulant and antithrombotic action of novel specific inhibitors of thrombin

Holmer, E.; Mattsson, C.; Nilsson, S., 1982:
Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits

Nieuwenhuizen, W.; Voskuilen, M.; Hermans, J., 1982:
Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y)

Douglas, A.S.; McNicol, G.P., 1968:
Anticoagulant and fibrinolytic drugs

Ji, L.X.; Zhang, L.Y.; Xu, L.N., 1981:
Anticoagulant and fibrinolytic effects of total glycosides of Chi-Shao (Paeonia lactiflora) in rats

Budzynski, A.Z.; Olexa, S.A.; Brizuela, B.S.; Sawyer, R.T.; Stent, G.S., 1981:
Anticoagulant and fibrinolytic properties of salivary proteins from the leech Haementeria ghilianii

Gritsiuk, A.I.; Petrus', V.G.; Bol'shakova, R.M.; Beliaeva, K.G., 1973:
Anticoagulant and fibrinolytic therapy of myocardial infarct

Dyken, M.L., 1983:
Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke

Baumgartner, G., 1968:
Anticoagulant and surgical treatment of cerebrovascular accidents

Ogston, D.; Douglas, A.S., 1971:
Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects

Ogston, D.; Douglas, A.S., 1971:
Anticoagulant and thrombolytic drugs. II. Clinical aspects

Nielsen, H.K.; Lassen, J.F.; Ravn, H.B.; Husted, S.E., 1995:
Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism

Barkagen, Z.S.; Val'tseva, I.A.; Mitel'man, L.Sh.; Talyzin, F.F.; Iagodkin, S.I., 1967:
Anticoagulant and toxic properties of various fractions of the venom of the Middle Asian cobra

Rainsford, S.G.; Aronstam, A.; Holborow, E.J.; McLellan, D.S., 1982:
Anticoagulant antibodies in the synovial membranes of patients suffering from haemophilia, rheumatoid arthritis and other rheumatic disorders

Harries, A.D.; Birtwell, A.J.; Jones, D.B., 1981:
Anticoagulant control

Poller, L., 1972:
Anticoagulant control and standardization of coagulation reagents

Rogulj, B.; Adamović, R.; Mihalić, H.; Hauptmann, E., 1965:
Anticoagulant effect of acenocoumarol (Syncoumar "Egyt")

Boffa, M.C.; Barbier, D.; de Angulo, M., 1983:
Anticoagulant effect of cardiotoxins

Tersenov, O.A.; Chabanov, M.K., 1981:
Anticoagulant effect of phosphatidylserine

Raccuglia, G.; Waterman, N.G., 1969:
Anticoagulant effect of sodium cephalothin (Keflin)

Rybak, B.; Boivinet, L.; Rannou, C., 1967:
Anticoagulant effect, per os, of rare earths salts

Amris, C.J.; Hilden, M., 1968:
Anticoagulant effects of Trasylol: in vitro and in vivo studies

Kindness, G.; Long, W.F.; Williamson, F.B., 1980:
Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas

Bergqvist, D.; Hedner, U.; Sjörin, E.; Holmer, E., 1983:
Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously

Boffa, M.C.; Delori, P.; Soulier, J.P., 1972:
Anticoagulant factors from Viperidae venoms. Platelet phospholipid inhibitors

Walsh, A.C., 1983:
Anticoagulant for dementia?

Zer, M.; Chaimoff, C.; Dintsman, M., 1972:
Anticoagulant ileus with intestinal necrosis

Easton, J.D.; Byer, J.A.; Sherman, D.G., 1981:
Anticoagulant in cerebrovascular disease

Schachner, S.H.; Kirschner, L.P.; Roll, W.E., 1969:
Anticoagulant induced intramural hematoma of the small intestine

Anonymous, 1971:
Anticoagulant interactions

Hofstetter, J.R.; Clément, F., 1970:
Anticoagulant malingerers ("dicoumarol eaters")

Umlas, J.; Taff, R.H.; Gauvin, G.; Swierk, P., 1983:
Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses

Lorberbaum, H., 1971:
Anticoagulant monitoring of volunteers using prothrombin activity tests with abnormal control plasmas: a cooperative study

Glen, S.; Grosset, D.; Lees, K., 1995:
Anticoagulant monitoring with transcranial Doppler

Lakin, K.M.; Smirnova, T.V.; Karaseva, M.G., 1968:
Anticoagulant of indirect action nitropharin

Bruhn, H.D.; Jipp, P.; Schellmann, J.; Sedlmeyer, I.; Müller-Wiefel, H.; Borm, D., 1972:
Anticoagulant prevention in surgical and conservative treatment of chronic pelvic and leg artery occlusions

Klok, P.A., 1973:
Anticoagulant prevention of massive pulmonary embolism in surgical patients

Allalouf, D.; Ber, A.; Rechnic, J.; Sharon, N., 1967:
Anticoagulant properties of an acid mucopolysaccharide preparation isolated from rat kidney

Holmer, E., 1980:
Anticoagulant properties of heparin and heparin fractions

Nagasawa, K.; Uchiyama, H., 1984:
Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III

Rehse, K.; Bienfait, R., 1984:
Anticoagulant properties of heterocyclic 1,3-diketones

Sterrenberg, L.; van Liempt, G.J.; Nieuwenhuizen, W.; Hermans, J., 1984:
Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase

Dizhenina, I.I., 1983:
Anticoagulant properties of the electrophoresis of pyrazolone preparations in ischemic heart disease

Bauer, F.; Schulz, P.; Reber, G.; Bouvier, C.A., 1983:
Anticoagulant properties of three mucopolysaccharides used in rheumatology

Sevitt, S., 1966:
Anticoagulant prophylaxis against venous thrombosis and pulmonary embolism after injury

Neef, H.; Wenzel, K.P., 1971:
Anticoagulant prophylaxis in alloplastic cardiac valve implants

Bŭchvarova, V., 1983:
Anticoagulant prophylaxis in pregnant patients with artificial heart valve prostheses

Skinner, D.B.; Salzman, E.W., 1967:
Anticoagulant prophylaxis in surgical patients

Schadenböck, R.; Schlag, G., 1968:
Anticoagulant prophylaxis of thromboembolism in fractures of the pelvic area

Eskeland, G.; Solheim, K.; Skjörten, F., 1966:
Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures. A controlled clinical trial

Pandya, B.V.; Budzynski, A.Z., 1984:
Anticoagulant proteases from western diamondback rattlesnake (Crotalus atrox) venom

Bergmann, M.; Hubmer, G., 1965:
Anticoagulant provocation for the diagnosis of hematuria of unknown pathogenesis

Skorik, V.I.; Safonova, E.S.; Sternin, M.O.; Zelikson, B.M.; Malikova, T.M., 1984:
Anticoagulant tactics when working with membrane oxygenator "Sever-OMR"

Drapkin, A.; Merskey, C., 1972:
Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction

Colling, A.; Bird, A.; Aitchison, C.I., 1969:
Anticoagulant therapy after myocardial infarction

Goguel, M.; Noël, G.; Gillet, J.Y.; Girardel, J.M.; Muller, P.; Mayer, G., 1970:
Anticoagulant therapy and breast-feeding: study of the passage of phenyl-2-dioxo, 1,3 indane in the maternal milk

Loeliger, E.A., 1970:
Anticoagulant therapy and coronary thrombosis

Hachen, H.J., 1968:
Anticoagulant therapy and hemorrhagic accidents

Schaller, K., 1974:
Anticoagulant therapy and late recurrence of myocardial infarcts

Selzer, A., 1980:
Anticoagulant therapy and myocardial infarction

Heine, H.; Schmidt, H.; Mach, H.; Jaruszewski, H., 1971:
Anticoagulant therapy and prophylaxis in arterial vascular diseases

Anonymous, 1982:
Anticoagulant therapy and pulmonary embolism

Hildreth, D.H., 1972:
Anticoagulant therapy and rectus sheath hematoma

Herbert, D.C., 1968:
Anticoagulant therapy and the acute abdomen

McDonald, M.M.; Hathaway, W.E., 1982:
Anticoagulant therapy by continuous heparinization in newborn and older infants

Olwin, J.H.; Koppel, J.L., 1969:
Anticoagulant therapy during pregnancy. A new approach

Prudhomme, F.; Duport, G., 1970:
Anticoagulant therapy during the acute period myocardial infarct

Genton, E.; Turpie, A.G., 1983:
Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction

Kamiya, K., 1965:
Anticoagulant therapy following vascular surgery

Walsh, A.C., 1995:
Anticoagulant therapy for dementia

Ratner, J.; Rosenberg, G.; Kral, V.A.; Engelsmann, F., 1972:
Anticoagulant therapy for senile dementia

Watanabe, T.; Hara, T.; Nakamichi, S.; Konishi, T.; Inaba, S., 1971:
Anticoagulant therapy for the mitral disease with special reference to preoperative treatment

Vorster, C., 1968:
Anticoagulant therapy from the surgical viewpoint

Järhult, B.; Romelsjö, A., 1981:
Anticoagulant therapy in a primary care center

Goldman, L., 1980:
Anticoagulant therapy in acute myocardial infarct. Therapeutic indications based on incomplete experimental data

Tewari, H.K.; Khosla, P.K.; Garg, S.P., 1981:
Anticoagulant therapy in branch vein occlusion

Horváth, A.; Monoki, S., 1967:
Anticoagulant therapy in cardiac and arterial diseases

Maurice, P., 1970:
Anticoagulant therapy in cardiology

Latallo, Z.S.; Malanowicz, W., 1970:
Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants

Latallo, Z.S.; Malanowicz, W., 1971:
Anticoagulant therapy in cardiovascular diseases. II. Clinical problems of anticoagulant therapy

Das Gupta, A., 1970:
Anticoagulant therapy in cerebrovascular disorders

Kosaka, T.; Nagase, M.; Suzuki, Y.; Kobayashi, N., 1980:
Anticoagulant therapy in combination with pulse therapy--about 12 nephritic patients with nephrotic syndrome--

Roos, J.P., 1972:
Anticoagulant therapy in coronary disease

Borchgrevink, C.F., 1965:
Anticoagulant therapy in coronary heart disease. (Review 1963)

Mihailović, V., 1966:
Anticoagulant therapy in coronary insufficiency

Jaffe, H.L., 1970:
Anticoagulant therapy in coronary ischemic disease

Popov, V.A., 1974:
Anticoagulant therapy in destructive processes in the abdominal organs

Cathelineau, G., 1982:
Anticoagulant therapy in diabetic retinopathy

Koller, F., 1968:
Anticoagulant therapy in geriatrics

Lübcke, P., 1970:
Anticoagulant therapy in heart disease

Bergstein, J.M., 1981:
Anticoagulant therapy in human renal disease

Czestochowska, E., 1993:
Anticoagulant therapy in ischaemic heart disease in seafarers

Koyama, T.; Narita, M., 1983:
Anticoagulant therapy in kidney diseases, with special reference to the effectiveness of warfarin over a long period

Schmutzler, R., 1969:
Anticoagulant therapy in mitral stenosis

Anonymous, 1965:
Anticoagulant therapy in myocardial infarct

Wright, I.S., 1969:
Anticoagulant therapy in myocardial infarction

Bjerkelund, C., 1971:
Anticoagulant therapy in myocardial infarction. An evaluation of the present state

Gross, H.; Vaid, A.K.; Levine, H.S.; Hasson, J., 1972:
Anticoagulant therapy in myocardial infarction: an overview of methodology

Lund, F.; Tillgren, C., 1966:
Anticoagulant therapy in occlusive peripheral arterial disease and its evaluation

Borchgrevink, C.F., 1967:
Anticoagulant therapy in patients with angina pectoris

Thornes, R.D., 1969:
Anticoagulant therapy in patients with cancer

Chiefari, M.; Brita, G.; Sbordone, L.; Pizzicato, B., 1980:
Anticoagulant therapy in patients with heart valve prostheses. Considerations on teratogenesis and anesthesia

Benavides, P.H.; Gorodezky, M.; Hurtado del Río, D., 1968:
Anticoagulant therapy in patients with the Starr-Edwards prosthesis

Lo Cicero, G.; Brina, A., 1972:
Anticoagulant therapy in pregnant women with cardiac valve prostheses: critical study

Aurekoski, H., 1966:
Anticoagulant therapy in retinal vein occlusion

Dry, J., 1968:
Anticoagulant therapy in the aged

Gournay, J., 1982:
Anticoagulant therapy in the elderly : limitations and contraindications

Moe, N., 1982:
Anticoagulant therapy in the prevention of placental infarction and perinatal death

Eide, M., 1971:
Anticoagulant therapy in vascular surgery for acute obliterations

Lasch, H.G., 1964:
Anticoagulant therapy of Marchiafava anemia

Sorensen, O.H.; Friis, T.; Wjorgensen, A.W.; Jorgensen, M.B.; Bnissen, N.I., 1968:
Anticoagulant therapy of acute myocardial infarct and its sequelae

Schimpf, K., 1967:
Anticoagulant therapy of arterial occlusive diseases

Baker, R.N.; Broward, J.A.; Fang, H.C.; Fisher, C.M.; Groch, S.N.; Heyman, A.; Karp, H.R.; McDevitt, E.; Scheinberg, P.; Schwartz, W.; Toole, J.F., 1966:
Anticoagulant therapy of cerebral infarction: report of a national cooperative study

Meyer, A., 1965:
Anticoagulant therapy of heart infarct

Misharev, O.S.; Dmitriev, V.V., 1982:
Anticoagulant therapy of hemostatic disorders in suppurative septic diseases in children

Adler, D., 1969:
Anticoagulant therapy of induratio penis plastica

Buyse, F.G.; Wormgoor, B.H.; Bernard, J.T.; Koudstaal, J., 1974:
Anticoagulant therapy of patients with repeated placental infarction

Hess, H., 1966:
Anticoagulant therapy of peripheral arterial thrombosis

McDevitt; McDowell, F.H., 1968:
Anticoagulant therapy of the completed stroke

Schöndorf, T., 1973:
Anticoagulant therapy of thromboembolism. I

Poller, L., 1968:
Anticoagulant therapy standards: results of two national surveys

Bokarev, I.N.; Kabaeva, E.V., 1984:
Anticoagulant therapy with antivitamins K

Tejani, N., 1973:
Anticoagulant therapy with cardiac valve prosthesis during pregnancy

Gritsiuk, A.I.; Petrus', V.G., 1974:
Anticoagulant therapy with "regulated hypocoagulation of the blood" in the initial period of myocardial infarct

Wessler, S., 1974:
Anticoagulant therapy--1974

Wright, I.S., 1969:
Anticoagulant therapy-practical management

Fischer, M., 1970:
Anticoagulant therapy. I. (Possibilities and limits)

Fischer, M., 1970:
Anticoagulant therapy. II. (Possibilities and limits)

Iturbe Alessio, I.; Fabrega Ramírez, J.R., 1984:
Anticoagulant therapy. Practical recommendations for its use

Gross, H.; Hasson, J.; Solomon, S., 1971:
Anticoagulant therapy: a critique

Shleser, I.H., 1969:
Anticoagulant therapy: controversial after two decades

Josso, F.; Cosson, A., 1970:
Anticoagulant therapy: physiologic problems

Hampton, J.W., 1974:
Anticoagulant therapy: through a glass darkly

Schmidt, J., 1968:
Anticoagulant treatment and cerebrovascular pathology

Himbert, J.; Sée, E.; Thiroloix, P.; Lenègre, J., 1971:
Anticoagulant treatment and digestive hemorrhages

Gibelin, P., 1995:
Anticoagulant treatment and dilated cardiomyopathy

Egberg, N.; Thulin, L., 1973:
Anticoagulant treatment during abdominal surgery in a case of antithrombin 3 deficiency

Holm, J.; Scherstén, T., 1972:
Anticoagulant treatment during and after embolectomy

Ohler, W.G., 1966:
Anticoagulant treatment following thrombolytic therapy

Köstering, H.; Walther, C.; Quellhorst, E.; Wigger, W.; Scheler, F., 1970:
Anticoagulant treatment for avoiding the shunt-induced thrombosis in patients on hemodialysis

Anonymous, 1967:
Anticoagulant treatment for myocardial infarction

Malanowicz, W., 1967:
Anticoagulant treatment in coronary disease

Royston, G.R., 1968:
Anticoagulant treatment in coronary heart disease

Grimsgaard, C.; Hald, J., 1971:
Anticoagulant treatment in coxarthrosis surgery

Courtine, J.C., 1971:
Anticoagulant treatment in current general surgery

Schneer, J.H.; Chipail, A.; Constantinescu, V.; Brumăr, O.M., 1973:
Anticoagulant treatment in glomerular nephropathies in children

Bukowski, Z., 1971 :
Anticoagulant treatment in myocardial infarct

Anonymous, 1969:
Anticoagulant treatment in persons suspected of development of infarction (preinfarctsymptoms)

Di Fabio, D.; Lucchelli, P.; Mezzacapo, B.; Peronace, B.; Respighi, E., 1970:
Anticoagulant treatment in pregnant with heart valve prosthesis: therapeutic problems

Bianchi, T.; Trabattoni, P.; Losapio, G.M.; Vicini, D., 1967:
Anticoagulant treatment in reconstructive arterial surgical operations

Fayard, J.M.; Garrec, L.; Maurice, P., 1974:
Anticoagulant treatment in subjects over 70 years old

Sorensen, O.H.; Friis, T.; Jorgensen, A.W.; Jorgensen, M.B.; Nissen, N.I., 1969:
Anticoagulant treatment of acute coronary thrombosis

Marques, J.S., 1973:
Anticoagulant treatment of acute deep venous thrombosis

Hilden, T., 1967:
Anticoagulant treatment of ischaemic heart disease

Gorbacheva, F.E., 1971:
Anticoagulant treatment of ischemic insults

Rymaszewski, Z.; Berent, H.; Cybulska, I., 1971:
Anticoagulant treatment of outpatients in the light of personal observations

Godal, H.C., 1971:
Anticoagulant treatment of pulmonary embolism

Bratić-Mikes, V., 1973:
Anticoagulant treatment of pulmonary thromboembolism

Owen, C.A., 1982:
Anticoagulant treatment of rats with Walker 256 carcinosarcoma

Coon, W.W., 1972:
Anticoagulant treatment of venous thromboembolism

Langer, B.; Wolosker, M.; Albers, M.T., 1982:
Anticoagulant treatment with heparin

Stoichiţă-Papilian, M.; Creţescu, R., 1972:
Anticoagulant treatment with intravenous administration of heparin. Criteria of establishment of the dosage and rhythm of administration

Cornu, P., 1971:
Anticoagulant treatments and surgery. Biological bases

Olsson, J.E.; Brechter, C.; Bäcklund, H.; Krook, H.; Müller, R.; Nitelius, E.; Olsson, O.; Tornberg, A., 1980:
Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks

Güven, K.C.; Ulutin, S.B.; Mutluay, E.; Ulutin, O.N., 1973:
Anticoagulant-antithrombin and fibrinolytic actions of extract of marine alga Corallina rubens L

Hofmann, B.; Lösche, W.; Hofmann, J.; Till, U.; Thielmann, K., 1980:
Anticoagulant-free prepared blood platelets and the effect of calcium on their aggregation behaviour

Azizkhan, R.; Piepgrass, W.; Wilhelm, M.C., 1982:
Anticoagulant-induced hematomas of the small intestine

Lloyd, D.A.; Immelman, E.J.; Wright, M.G., 1973:
Anticoagulant-induced intramural haematoma of the bowel

Diamond, M.T.; Fell, S.C., 1973:
Anticoagulant-induced massive hemothorax

Shields, R.W.; Laureno, R.; Lachman, T.; Victor, M., 1984:
Anticoagulant-related hemorrhage in acute cerebral embolism

Suttie, J.W., 1973:
Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1

Gever, L.N., 1984:
Anticoagulants ...and what to teach your patient about them

Fleming, H.A., 1973:
Anticoagulants after mitral valvotomy

Oliver, M.F., 1981:
Anticoagulants after myocardial infarction in the elderly

Cade, J.F.; Hirsh, J.; Clarebrough, J.K., 1970:
Anticoagulants after open-heart surgery

Scott, W.W.; Fishman, E.K.; Siegelman, S.S., 1984:
Anticoagulants and abdominal pain. The role of computed tomography

Shats, V.Ia.; Druian, B.D., 1968:
Anticoagulants and body resistance

Anonymous, 1966:
Anticoagulants and cerebral infarction

Dry, J., 1965:
Anticoagulants and cerebrovascular accidents

McCullough, J.D., 1980:
Anticoagulants and continuous epidural anesthesia

Fishbein, M., 1969:
Anticoagulants and coronary artery disease

Mackinnon, J., 1969:
Anticoagulants and coronary heart disease

Coon, W.W., 1967:
Anticoagulants and drug interaction

Stuart, J.; Lucas, G.S.; Caldwell, N.M.; Kenny, M.W.; Meakin, M.; Aillaud, M.F.; Juhan-Vague, I., 1984:
Anticoagulants and erythrocyte filterability

Maat, B.; Hilgard, P., 1981:
Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems

Messini, M., 1967:
Anticoagulants and fibrinolytics in myocardial infarct

Kroll, S.S.; Miller, M.J.; Reece, G.P.; Baldwin, B.J.; Robb, G.L.; Bengtson, B.P.; Phillips, M.D.; Kim, D.; Schusterman, M.A., 1995:
Anticoagulants and hematomas in free flap surgery

Romanucci, D.; Jakovic, L.G.; Smedberg, K., 1974:
Anticoagulants and hemorrhage-breast necrosis: a case report

Stephenson, S.F., 1966:
Anticoagulants and mitral valvotomy: a nine-year survey

Casares, R., 1974:
Anticoagulants and myocardial infarct

Poller, L., 1981:
Anticoagulants and myocardial infarction

Anonymous, 1967:
Anticoagulants and oral surgery

Bollinger, A., 1980:
Anticoagulants and platelet active drugs in arterial occlusive disease

Van Aken, W.G., 1982:
Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease

Lanfranchi, C.; Olivier, C.; Boudot De La Motte, E.; Bavoux, F., 1982:
Anticoagulants and pregnancy. Apropos of a case of embryopathy caused by acenocoumarol

Robert D'Eshougues, J., 1965:
Anticoagulants and rheumatologic therapeutics

Cocks, J.R., 1970:
Anticoagulants and the acute abdomen

Mathis, A.; Camuzet, F., 1982:
Anticoagulants and the eye

Anonymous, 1994:
Anticoagulants and the isolation of mycobacteria from blood

Kimerle, L., 1974:
Anticoagulants and the oral surgery patient

Jacobs, P., 1972:
Anticoagulants and the surgeon

Keil, E., 1971:
Anticoagulants and their importance in dental surgery

Haas-Weston, C.F., 1971:
Anticoagulants and their site of action

Soyka, D., 1980:
Anticoagulants and thrombocyte aggregation inhibitors in cerebrovascular disorders

Spitzer, W.; Durst, O.E.; Lang, E., 1983:
Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey

Martorell, F., 1983:
Anticoagulants and thromboembolic disease

Appel, W., 1971:
Anticoagulants and thrombolytic agents in pregnancy and puerperium

Workman, M.L., 1994:
Anticoagulants and thrombolytics: what's the difference?

Hilgard, P., 1983:
Anticoagulants and tumor growth: pharmacological considerations

Lüders, K.; Rahmer, H.; Keimer, F., 1981:
Anticoagulants and tumor metastasis. Clinical examination

Border, W.A., 1984:
Anticoagulants are of little value in the treatment of renal disease

Kincaid-Smith, P., 1984:
Anticoagulants are of value in the treatment of renal disease

Kiehl, B.L.; Stott, P.B.; Huang, A.C.; Buthala, D., 1973:
Anticoagulants as inhibitors of reverse transcriptase activity

Nowak, W., 1967:
Anticoagulants as therapeutic agents, or, on the prevention of thromboebolism in accident injuries

Roberts, H.J., 1966:
Anticoagulants during dental surgery

Alieff, A., 1969:
Anticoagulants during pregnancy following artificial heart valve implantation

Danel, I.; Cooper, R., 1984:
Anticoagulants during pregnancy for mechanical prosthetic valves

Malcolm, A.D., 1980:
Anticoagulants for heart disease

Brettell, H.R., 1971:
Anticoagulants in acute coronary disease. Relapse after termination of therapy

Anonymous, 1973:
Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial

Wasserman, A.J., 1969 :
Anticoagulants in acute myocardial infarction: the last (?) word

Franciosi, R.A., 1972:
Anticoagulants in blood for exchange transfusion

Hainaut, J.; Monteil, R.; Migne, J., 1971:
Anticoagulants in burn patients

Cookson, H., 1969:
Anticoagulants in cardiac infarction

Nahum, L.H., 1966:
Anticoagulants in cerebrovascular disease

Giguère, R., 1966:
Anticoagulants in cerebrovascular disorders

Sinha, B.C., 1966:
Anticoagulants in coronary heart disease

Mitchell, J.R., 1981:
Anticoagulants in coronary heart disease--retrospect and prospect

Solheim, K., 1967:
Anticoagulants in hip fracture

Baumgartner, D., 1970:
Anticoagulants in intermittent cerebrovascular insufficiency

Zajarías, S., 1969:
Anticoagulants in ischemic heart diseases

Anonymous, 1972:
Anticoagulants in mitral valve disease

Walker, W.G., 1969:
Anticoagulants in myocardial infarction

Sprung, O., 1973:
Anticoagulants in old age

Prentice, C.R.; McNicol, G.P., 1971:
Anticoagulants in peripheral vascular disease

Hamming, J.J., 1966:
Anticoagulants in peripheral vascular disorders

Ludwig, H., 1970:
Anticoagulants in pregnancy and puerperium

Hirsh, J.; Cade, J.F.; Gallus, A.S., 1972:
Anticoagulants in pregnancy: a review of indications and complications

Caissel, J., 1973:
Anticoagulants in prostatic surgery

Kincaid-Smith, P., 1969:
Anticoagulants in renal disease

Herdman, R.C.; Edson, R.; Pickering, R.J.; Fish, A.J.; Marker, S.; Good, R.A., 1970:
Anticoagulants in renal disease in children

Gilson, S.B., 1969:
Anticoagulants in renal failure

Fleming, H.A., 1971:
Anticoagulants in rheumatic heart-disease

Klinger, A.D.; Perez, A., 1972:
Anticoagulants in sickle cell disease

Schulte, B.P., 1966:
Anticoagulants in the neurological clinic

Anonymous, 1971:
Anticoagulants in the prevention of strokes caused by occlusive vascular disease

Kierulf, P., 1971:
Anticoagulants in the prophylaxis and therapy of venous thrombosis

Ries, J.; Ludwig, H.; Appel, W., 1968:
Anticoagulants in the radiotherapy of genital carcinomas in women. I. Squamous cell carcinoma

Pollak, V.E., 1970:
Anticoagulants in the treatment of renal disease

Weigelin, E.; Pütz, H., 1970:
Anticoagulants in the treatment of venous thrombosis of the retina

Anonymous, 1972:
Anticoagulants in thromboembolism

Bharucha, E.P.; Bhatia, K.C., 1966:
Anticoagulants in transient cerebral ischaemic episodes

Thies, H.A., 1970:
Anticoagulants in traumatology

Hirsh, J.; Gallus, A.S., 1974:
Anticoagulants in venous thromboembolism. Prophylactic and therapeutic use

Kincaid-Smith, P.; Saker, B.M.; Fairley, K.F., 1968:
Anticoagulants in "irreversible" acute renal failure

Rapaka, R.S.; Roth, J.; Goehl, T.J.; Prasad, V.K., 1981:
Anticoagulants interfere with analysis for furosemide in plasma

Sinha, B.C., 1972:
Anticoagulants on platelet adhesiveness in myocardial infarction

Volger, E.; Theiss, W., 1983:
Anticoagulants or thrombocyte aggregation inhibitors in the prevention of recurrent heart infarction?

Muirhead, C.R.; Triantaphyllopoulos, D.C., 1971:
Anticoagulants produced by thrombin from fibrin, the effect on blood coagulation, some physical characteristics

Robinson, D.S., 1974:
Anticoagulants updated--application in coronary artery disease

Jungers, P.; Dougados, M.; Ganzegel, C.; Kremp, O.; Jacques, C.; Noel, L.H.; Josso, F., 1980:
Anticoagulants with antithrombinase activity in systemic lupus erythematosus

Rabinovitch, A., 1984:
Anticoagulants, platelets, and instrument problems

Moore, F.D.; Osteen, R.T.; Karp, D.D.; Steele, G.; Wilson, R.E., 1981:
Anticoagulants, venous thromboembolism, and the cancer patient

Naess, K., 1970:
Anticoagulants--antiphlogistics--acetylsalicylic acid. A note on interaction

Striegler, G., 1969:
Anticoagulants. 43

Mismetti, P.; Decousus, H., 1995:
Anticoagulants. Antivitamins K: principles and rules of use, posology

Decousus, H.; Mismetti, P., 1995:
Anticoagulants. Heparin: principles and rules of use, posology

Naess, K., 1968:
Anticoagulants. Mechanism behind variation in effect

Marx, R., 1973:
Anticoagulants. Various developmental starting points on direct antithrombins as antithrombotic agents

Kingdon, H.S., 1973:
Anticoagulants: a guide for practitioners

Anonymous, 1968:
Anticoagulants: antivitamin K

Gallus, A.S., 1982:
Anticoagulants: the state of the art

Theiss, W., 1994:
Anticoagulants: when and how?

Perfil'ev, D.F., 1972:
Anticoagulase reaction in acute purulent processes in the abdominal cavity of staphylococcal etiology

Kudriashov, B.A.; Pastorova, V.E.; Liapina, L.A., 1981:
Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin

Kudrjashov, B.A.; Pastorova, V.E.; Lyapina, L.A., 1983:
Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo

Serebriakova, T.N.; Andreenko, G.V.; Maksimova, R.A.; Tsymanovich, S.T.; Murashova, N.L., 1984:
Anticoagulating properties of fungal proteases tricholysine (triase) and longolytin

Shitikova, A.S.; Papaian, L.P., 1970:
Anticoagulation activity in the blood of patients with acute and chronic leukemia

Belikov, P.P., 1971:
Anticoagulation activity of saliva

Sigwart, U., 1995:
Anticoagulation after intracoronary stent insertion

Beck, J.R.; Pauker, S.G., 1981:
Anticoagulation and atrial fibrillation in the bradycardia-tachycardia syndrome

Wipf, J.E., 1995:
Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice

Hester, J.P.; Ayyar, R., 1984:
Anticoagulation and electrolytes

Hart, R.G.; Coull, B.M.; Miller, V.T., 1983:
Anticoagulation and embolic infarction

Sonkin, N., 1966:
Anticoagulation and gunshot concussion in eardrum bleeding

Laerum, F.; Holm, H.A.; Abildggard, U., 1980:
Anticoagulation and post-phlebographic thrombosis

Ingram, G.I.; Hambleton, G., 1970:
Anticoagulation and pregnancy

Dernier, J., 1968:
Anticoagulation and tooth extraction

Hall, G.H.; Holman, H.M.; Webster, A.D., 1970:
Anticoagulation by ancrod for haemodialysis

Parrilla, N.; Ansell, J., 1982:
Anticoagulation by constant subcutaneous heparin infusion

Mehta, R.L., 1994:
Anticoagulation during continuous renal replacement therapy

Rao, T.L.; El-Etr, A.A., 1981:
Anticoagulation following placement of epidural and subarachnoid catheters: an evaluation of neurologic sequelae

Wingfield, J.G., 1969:
Anticoagulation for antenatal thrombo-embolic disease

Hussain, A.; Cox, J.G., 1995:
Anticoagulation for nonrheumatic atrial fibrillation: the dilemma

Salzman, E.W.; Harris, W.H.; DeSanctis, R.W., 1966:
Anticoagulation for prevention of thromboembolism following fractures of the hip

Koehler, P.J.; Jager, J.; Verbiest, H.; Vecht, C.J., 1995:
Anticoagulation for radiation injury

Yeh, T.J., 1968:
Anticoagulation for the patients with cardiac valve prostheses

Bass, E., 1983:
Anticoagulation in cerebral embolism

Butler, R.B., 1971:
Anticoagulation in cerebrovascular disease

Kolár, L.; Wieberdink, J.; Reneman, R.S., 1973:
Anticoagulation in microvascular surgery

Carpenter, J.L.; McAllister, C.K., 1983:
Anticoagulation in prosthetic valve endocarditis

Bodnar, A.G.; Hutter, A.M., 1984:
Anticoagulation in valvular heart disease preoperatively and postoperatively

Golden, S.M.; O'Brien, W.F.; Metz, S.A., 1982:
Anticoagulation of autologous cord blood for neonatal resuscitation

Strezh, N.P.; Loginova, M.N., 1973:
Anticoagulation properties of blood plasma in children with respiratory pathology

Anonymous, 1968:
Anticoagulation recidivans

Anderson, J.H.; Gianturco, C.; Wallace, S.; Dodd, G.D.; DeJongh, D., 1974:
Anticoagulation techniques for angiography. An experimental study

Saurugg, D.; Summer, K., 1973:
Anticoagulation therapy and intracranial hemorrhage

Yatsu, F.M.; Mohr, J.P., 1982:
Anticoagulation therapy for cardiogenic emboli to brain

Clarke-Pearson, D.L.; Synan, I.S.; Creasman, W.T., 1983:
Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy

Thompson, J.; Loeliger, E.A., 1984:
Anticoagulation therapy in patients with infectious endocarditis: a therapeutic dilemma

Chlumský, J., 1994:
Anticoagulation therapy in patients with valvular prostheses

Gofman, L.I.; Markelova, Z.I., 1971:
Anticoagulation therapy in the prevention of chronic coronary insufficiency (according to polyclinic data)

Stanulović, D., 1973:
Anticoagulation treatment of acute myocardial infarct

Pistotnik, M., 1973:
Anticoagulation treatment of cerebrovascular disorders

Schöndorf, T., 1973:
Anticoagulation treatment of thromboembolic diseases. II

Stormorken, H., 1972:
Anticoagulation treatment. Patients in whom administration is difficult

Kumon, K.; Tanaka, K.; Nakajima, N.; Naito, Y.; Fujita, T., 1984:
Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation

Wright, I.S., 1966:
Anticoagulation--drugs, tests and dangers

al-Saden, P., 1994:
Anticoagulation-induced epistaxis

Painter, T.D., 1983:
Anticoagulation. Current approach to heparin and warfarin therapy

Edelson, R., 1974:
Anticoagulation. II. Anticoagulant usage in cerebrovascular disease

Ohara, I.; Kijima, M., 1966:
Anticoagulative activity of omega-heparin in the intramuscular application

Lakin, K.M.; Zimakov, I.A.; Pliushchev, V.E.; Nadezhdina, G.V.; Loseva, G.S., 1970:
Anticoagulative activity of salts of rare-earth elements

Donner, L.; Heyrovský, A., 1968:
Anticoagulative properties of the normal and atherosclerotic arterial wall

Binaghi, G.; Prevosti, L.; Mortarino, G.; Giani, P.; Bruno, L.; Soldati, B.; Folli, G., 1970:
Anticoagulatory therapy in myocardial infarct: case contribution

Mizzoni, R.H.; Lucas, R.A.; Smith, R.; Boxer, J.; Brown, J.E.; Goble, F.; Konopka, E.; Gelzer, J.; Szanto, J.; Maplesden, D.C.; DeStevens, G., 1970:
Anticoccidial activity in 1-[2-(cycloalkyl)- and 2-(cycloalkylmethyl-4-amino-5-pyrimidyl)methyl]pyridinium salts

McQuistion, T.E.; McDougald, L.R., 1981:
Anticoccidial activity of arprinocid and halofuginone

Ruff, M.D.; Reid, W.M.; Rahn, A.P.; McDougald, L.R., 1980:
Anticoccidial activity of narasin in broiler chickens reared in floor pens

Miller, M.W.; Mylari, B.L.; Howes, H.L.; Figdor, S.K.; Lynch, M.J.; Lynch, J.E.; Koch, R.C., 1980:
Anticoccidial derivatives of 6-azauracil. 3. Synthesis, high activity, and short plasma half-life of 1-phenyl-6-azauracils containing sulfonamide substituents

Miller, M.W.; Mylari, B.L.; Howes, H.L.; Figdor, S.K.; Lynch, M.J.; Lynch, J.E.; Gupta, S.K.; Chappel, L.R.; Koch, R.C., 1981:
Anticoccidial derivatives of 6-azauracil. 4. A 1000-fold enhancement of potency by phenyl sulfide and phenyl sulfone side chains

Hymas, T.A., 1970:
Anticoccidial drugs: introductory remarks on techniques in battery trials

Johnson, J.; Reid, W.M., 1970:
Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens

Reid, W.M., 1970:
Anticoccidial drugs: objectives of symposium on development, selection, and testing

McDougald, L.R.; Keshavarz, K.; Rosenstein, M., 1981:
Anticoccidial efficacy of salinomycin (AHR-3096C) and compatibility with roxarsone in floor-pen experiments with broilers

Schulman, L.H.; Pelka, H., 1983:
Anticodon loop size and sequence requirements for recognition of formylmethionine tRNA by methionyl-tRNA synthetase

Murgola, E.J.; Prather, N.E.; Mims, B.H.; Pagel, F.T.; Hijazi, K.A., 1983:
Anticodon shift in tRNA: a novel mechanism in missense and nonsense suppression

Yoshida, M.; Takeishi, K.; Ukita, T., 1970:
Anticodon structure of GAA-specific glutamic acid tRNA from yeast

Evans, A.E.; Brown, B.; Marion, J.B., 1966:
Anticoincidence shielded gamma-ray spectrometer for nuclear reaction studies

Brzozowska-Jakowicka, M.; Krasowska, I., 1971:
Anticol poisoning in a 3-year-old boy

Bray, J.P.; Estess, F.; Bass, J.A., 1969:
Anticollagen antibodies following thermal trauma

Ripa, R.; Alvisi, R.; Salzano, S.; Baggioni, G.F., 1970:
Anticomplement action in vitro of animal phospholipids of various organs

Ripa, R.; Salzano, S.; Alvisi, R.; Baggioni, G.F., 1970:
Anticomplement action in vitro of renal phospholipids

Shirova, L.; Toshkov, A., 1981:
Anticomplement action of carbiphen, amopen and cephalothin in vitro and in vivo

Valguarnera, G., 1974:
Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies

Obchinnikov, N.M.; Bednova, V.N., 1968:
Anticomplement fluorescent antibody technic in experimental studies and serodiagnosis of syphilis

Huang, S.W., 1984:
Anticomplement function of heparin

Zeng, Y.; Shen, S.J.; Pi, G.H.; Ma, J.L.; Zhang, Q.; Zhao, M.L.; Dong, H.J., 1981:
Anticomplement immunoenzymatic method of detecting Epstein-Barr nuclear antigen in nasopharyngeal carcinoma cells and normal epithelial cells

Shigeta, S.; Baba, M.; Ogata, M.; Iijima, S.; Murai, C., 1981:
Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus

Mintz, L.; Miner, R.C.; Yeager, A.S., 1980:
Anticomplement immunofluorescence test that uses isolated fibroblast nuclei for detection of antibodies to human cytomegalovirus

Ryberg, B., 1983:
Anticomplementary activity in multiple sclerosis

Lassus, A.; Mustakallio, K.K., 1969:
Anticomplementary activity in serological tests for syphilis as a clue to connective tissue diseases of an auto-immune nature

Norgaard, O., 1974:
Anticomplementary activity in serum in myelomatosis

Glovsky, M.M.; Fudenberg, H.H., 1971:
Anticomplementary activity in unaggregated "purified" macroglobulin paraproteins

Di Perri, T.; Auteri, A., 1972:
Anticomplementary activity of 3,4,5 trimethoxy-benzoyl-epsilon aminocaproic acid as component in the treatment of myocardial infarct

Yamauchi, Y.; Matsumoto, J.; Horimatsu, T.; Isobe, T., 1981:
Anticomplementary activity of cinnarizine, and the relationship between complement and arteriosclerosis

Waldesbuhl, M.; Allan, R.; Meylan, A.; Isliker, H., 1970:
Anticomplementary activity of gamma G-immunoglobulins and of their subunits

Morrison, D.C.; Verroust, P.; Weigle, W.O., 1973:
Anticomplementary activity of lipid A isolated from lipopolysaccharides

Stelzner, A.; Urbach, H.; Brunnemann, H., 1971:
Anticomplementary and antigenic properties of complement-fixing antigens of respiratory syncytial virus

Balázs, V.; Fröhlich, M.M., 1966:
Anticomplementary effect of cryoglobulinemic sera and isolated cryoglobulins

Balázs, V.; Fröhlich, M., 1966:
Anticomplementary effect of cryoglobulinemic sera and of isolated cryoglobulins

Dioguardi, D.; Favoino, B.; Laurentaci, G., 1983:
Anticomplementary effects developed in vitro by two xenogeneic skin extracts on human sera

Gitnick, G.L.; Summerskill, W.H.; Soloway, R.D.; Ritman, S.; Schoenfield, L.J., 1973:
Anticomplementary hepatitis B antigen. Prognostic importance in chronic active liver disease

Di Perri, T., 1973:
Anticomplementary properties of cinnarizine

Lassus, A.; Förström, L.; Piha, H.J.; Kiistala, U., 1969:
Anticomplementary reactions and their relation to some auto-immune phenomena in syphilitic infection

Cream, J.J., 1973:
Anticomplementary sera in cutaneous vasculitis

Traub, W.H.; Lowrance, B.L., 1970:
Anticomplementary, anticoagulatory, and serum-protein precipitating activity of sodium polyanetholsulfonate

Starup, J., 1973:
Anticonception with the progestational hormone Depo-Provera

Myslobodsky, M.; Feldon, J.; Lerner, T., 1983:
Anticonflict action of sodium valproate. Interaction with convulsant benzodiazepine (Ro 5-3663) and imidazodiazepine (Ro 15-1788)

Barrett, J.E.; Gamble, E.H.; Zhang, L.; Guardiola-Lemaitre, B., 1994:
Anticonflict and discriminative stimulus effects in the pigeon of a new methoxy-chroman 5-HT1A agonist, (+)S 20244 and its enantiomers (+)S 20499 and (-)S 20500

Scheel-Krüger, J.; Petersen, E.N., 1982:
Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala

Engel, J.A.; Hjorth, S.; Svensson, K.; Carlsson, A.; Liljequist, S., 1984:
Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)

Wallace, J.E.; Becker, J.; Coppel, D.B.; Cox, G.B., 1983:
Anticonformity aspects of depression in mild depressive states

Meldrum, B.S.; Murugaiah, K., 1983:
Anticonvulsant action in mice with sound-induced seizures of the optical isomers of gamma-vinyl GABA

Meldrum, B.S.; Evans, M.C.; Braestrup, C., 1983:
Anticonvulsant action in the photosensitive baboon, Papio papio, of a novel beta-carboline derivative, ZK 91296

De Sarro, G.; Meldrum, B.S.; Reavill, C., 1984:
Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra

Gale, K.; Iadarola, M.J.; Casu, M., 1983:
Anticonvulsant action of GABAergic drugs: cellular and anatomical localization of their site of action in vivo

Peterson, D.W.; Collins, J.F.; Bradford, H.F., 1984:
Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures

Kosoĭ, M.Iu., 1981:
Anticonvulsant action of di-N-propylacetate combined with benzodiazepines, phenobarbital and phenytoin

Goto, M.; Morishita, S.; Fukuda, H., 1983:
Anticonvulsant action of diazepam in mice pretreated with caffeine

Croucher, M.J.; Collins, J.F.; Meldrum, B.S., 1982:
Anticonvulsant action of excitatory amino acid antagonists

Albertson, T.E.; Joy, R.M.; Stark, L.G., 1984:
Anticonvulsant action of fluzinamide (AHR-8559) on kindled amygdaloid seizures

Dobrescu, D.; Coeugniet, E., 1970:
Anticonvulsant action of imipramine and imitriptyline associated with phenobarbital, phenytoin and diazepam

Chmielewska, B., 1983:
Anticonvulsant action of new cyclic derivatives of phenylsuccinimides

Mutani, R.; Durelli, L.; Piredda, S.; Sechi, G.P.; Traccis, S., 1982:
Anticonvulsant action of pargyropyranone in various models of experimental epilepsy in the cat

Baldino, F.; Krespan, B.; Geller, H.M., 1984:
Anticonvulsant actions of fominoben: possible involvement of benzodiazepine receptors

Morgan, P.F.; Stone, T.W., 1982:
Anticonvulsant actions of the putative gamma-aminobutyric acid (GABA)-mimetic, ethylenediamine

Hitchcock, E.; Teixeira, M., 1982:
Anticonvulsant activation of pain-suppressive systems

Wimbish, G.H.; Jones, G.L.; Amato, R.J.; Peyton, G.A., 1980:
Anticonvulsant activities and brain concentrations of cyheptamide and carbamazepine

Marcucci, F.; Mussini, E.; Guaitani, A.; Fanelli, R.; Garattini, S., 1971:
Anticonvulsant activity and brain levels of diazepam and its metabolites in mice

Nau, H.; Löscher, W.; Schäfer, H., 1984:
Anticonvulsant activity and embryotoxicity of valproic acid

Parmar, S.S.; Joshi, P.C.; Ali, B.; Cornatzer, W.E., 1974:
Anticonvulsant activity and inhibition of respiration in rat brain homogenates by substituted oxadiazoles

Parmar, S.S.; Pandey, B.R.; Dwivedi, C.; Harbison, R.D., 1974:
Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines

Jaiswal, R.K.; Parmar, S.S.; Kumar, S.; James, E.C., 1982:
Anticonvulsant activity and monoamine oxidase inhibitory properties of substituted 1,2,4-triazoles

Singh, S.P.; Chaudhari, A.; Barthwal, J.P.; Parmar, S.S., 1974 :
Anticonvulsant activity and selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations by 1,3,5-trisubstituted pyrazolines

Kornet, M.J.; Thorstenson, J.H.; Lubawy, W.C., 1974:
Anticonvulsant activity of 1-alkyl-4-substituted 3,5-pyrazolidinediones

Dua, P.R.; Chatterji, S.K., 1981:
Anticonvulsant activity of 3-p-chlorophenoxy-1-n (3,4 dimethoxy phenyl) piperazinopropanol-2 (compound 65/359)

Chambon, J.P.; Molimard, J.C.; Calassi, R.; Maruani, J.; Rodier, D.; Sigault, G.; Leyris, R.; Roncucci, R.; Bizière, K., 1984:
Anticonvulsant activity of 4,9-dioxo-5,10-diazatetradecane (CM 40142), a new GABA derivative, in mice and photosensitive baboons)

De Riu, P.L.; Susini, G.; Ruju, P., 1982:
Anticonvulsant activity of Althesin on experimental epilepsy

Dikshit, S.K.; Tewari, P.V.; Dixit, S.P., 1972:
Anticonvulsant activity of Canscora decussata Roem. & Sch

Navarro Ruíz, A.; Bastidas Ramírez, B.E.; García Estrada, J.; García López, P.; Garzón, P., 1995:
Anticonvulsant activity of Casimiroa edulis in comparison to phenytoin and phenobarbital

Croucher, M.J.; Meldrum, B.S.; Krogsgaard-Larsen, P., 1983:
Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration

Baird-Lambert, J.; Dunlop, R.W.; Jamieson, D.D., 1980:
Anticonvulsant activity of a novel diterpene isolated from a soft coral of the genus Lobophytum

Millichap, J.G.; Pitchford, G.L.; Millichap, M.G., 1968:
Anticonvulsant activity of antiparkinsonism agents

Gupta, L.; Arora, R.B.; Singh, M., 1973:
Anticonvulsant activity of benziminazoles

Lasek, R.; Fischer, W.; Müller, M., 1983:
Anticonvulsant activity of beta-adrenolytics in electroshock

Login, I.S.; Dreifuss, F.E., 1983:
Anticonvulsant activity of clomiphene

Zand, R.; Izquierdo, I., 1980:
Anticonvulsant activity of cyclopentano amino acids

McCaughran, J.A.; Corcoran, M.E.; Wada, J.A., 1974:
Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats

Karler, R.; Cely, W.; Turkanis, S.A., 1974:
Anticonvulsant activity of delta9-tetrahydrocannabilol and its 11-hydroxy and 8alpha, 11-dihydroxy metabolites in the frog

Poncelet, M.; Etienne, S.; Doare, L.; Simon, P., 1984:
Anticonvulsant activity of diphenylhydantoin: pharmacological evidence for an alpha-adrenergic mechanism of action

Ljungberg, S.; Paalzow, L.; Ström, S., 1968:
Anticonvulsant activity of ectylurea in mice

Samuels, S.; Fish, I.; Schwartz, S.A., 1983:
Anticonvulsant activity of glycylglycine and delta-aminovaleric acid: evidence for glutamine exchange in amino acid transport

Chapman, A.G.; Croucher, M.J.; Meldrum, B.S., 1984:
Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice

Kulkarni, S.K.; Kurosawa, E., 1981:
Anticonvulsant activity of isolaureatin: a marine cyclic ether

Löscher, W., 1981:
Anticonvulsant activity of metabolites of valproic acid

van Dorsser, W.; Barris, D.; Cordi, A.; Roba, J., 1983:
Anticonvulsant activity of milacemide

Kouyoumdjian, J.C.; Ebadi, M., 1981:
Anticonvulsant activity of muscimol and gamma-aminobutyric acid against pyridoxal phosphate-induced epileptic seizures

Bapat, S.K.; Chandra, V., 1969:
Anticonvulsant activity of nialamide--a monoamine oxidase inhibitor

Parmar, S.S.; Dwivedi, C.; Ali, B.; Misra, R.S., 1972:
Anticonvulsant activity of nitrobenzamides and their inhibition of nicotinamide-adenine dinucleotide dependent oxidations

De Sarro, A.; De Sarro, G.; Chimirri, A.; Grasso, S.; Monforte, A.M.; Zappalà, M., 1994:
Anticonvulsant activity of pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c] pyridines and pyrrolo[2,1-f]purines in DBA/2 mice

Oja, S.S.; Kontro, P.; Lindén, I.B.; Gothóni, G., 1983:
Anticonvulsant activity of some 2-aminoethanesulphonic acid (taurine) derivatives

Clark, C.R.; Wells, M.J.; Sansom, R.T.; Norris, G.N.; Dockens, R.C.; Ravis, W.R., 1984:
Anticonvulsant activity of some 4-aminobenzamides

Madan, B.R.; Barar, F.S., 1974:
Anticonvulsant activity of some beta-adrenoceptor blocking agents in mice

Craig, C.R.; Deason, J.R., 1968:
Anticonvulsant activity of steroids, specificity of structure

Singh, S.P.; Auyong, T.K.; Parmar, S.S., 1974:
Anticonvulsant activity of substituted 4-thiazolidones

Breen, M.P.; Bojanowski, E.M.; Cipolle, R.J.; Dunn, W.J.; Frank, E.; Gearien, J.E., 1973:
Anticonvulsant activity of substituted benzoylpyridines

Wood, J.D.; Johnson, D.D.; Krogsgaard-Larsen, P.; Schousboe, A., 1983:
Anticonvulsant activity of the glial-selective GABA uptake inhibitor, THPO

Dasgupta, A.; Agarwal, S.S.; Basu, D.K., 1984:
Anticonvulsant activity of the mixed fatty acids of Elaeocarpus ganitrus roxb. (Rudraksh)

Hinko, C.N.; Seibert, K.; Crider, A.M., 1984:
Anticonvulsant activity of the nipecotic acid ester, (+/-)-m-nitrophenyl-3-piperidinecarboxylate

Simler, S.; Ciesielski, L.; Klein, M.; Mandel, P., 1982:
Anticonvulsant and antiaggressive properties of di-n-propyl acetate after repeated treatment

Sackeim, H.A.; Decina, P.; Prohovnik, I.; Malitz, S.; Resor, S.R., 1983:
Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action

Chaturvedi, A.K.; Parmar, S.S.; Bhatnagar, S.C.; Misra, G.; Nigam, S.K., 1974:
Anticonvulsant and antiinflammatory activity of natural plant coumarins and triterpenoids

Löscher, W., 1982:
Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice

Tripathi, S.; Ahmad, S.; Barthwal, J.P.; Tangri, K.K.; Bhargava, K.P., 1982:
Anticonvulsant and monoamine oxidase inhibitory activity of substituted oxadiazol-thiones

Hudson, R.D.; Wolpert, M.K., 1970:
Anticonvulsant and motor depressant effects of Diazepam

Mueller, A.L.; Dunwiddie, T.V., 1983:
Anticonvulsant and proconvulsant actions of alpha- and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro

Croucher, M.J.; Meldrum, B.S.; Collins, J.F., 1984:
Anticonvulsant and proconvulsant properties of a series of structural isomers of piperidine dicarboxylic acid

Meldrum, B.S.; Anlezark, G.M.; Adam, H.K.; Greenwood, D.T., 1982:
Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon

Spreafico, G., 1967:
Anticonvulsant and psychotropic effects of Tegretol in a group of epileptic children, with irregular behavior and mental deficiency

Mehta, V.L.; Malhotra, C.L., 1966:
Anticonvulsant and some neuropharmacological properties of 2-methyl-3-omicron-tolyl-6-chloro-4(3h)-quinazolone and related compounds